| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | actin binding | MYH9 MYH11 SPTA1 SPTBN1 TRPC5 ACTN4 ACTN1 NEB JMY DST SYNE2 MACF1 TRPV4 | 1.64e-05 | 479 | 131 | 13 | GO:0003779 |
| GeneOntologyMolecularFunction | actin filament binding | 1.93e-05 | 227 | 131 | 9 | GO:0051015 | |
| GeneOntologyMolecularFunction | store-operated calcium channel activity | 5.81e-05 | 12 | 131 | 3 | GO:0015279 | |
| GeneOntologyMolecularFunction | inositol 1,4,5 trisphosphate binding | 9.53e-05 | 14 | 131 | 3 | GO:0070679 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | MYH9 MYH11 CLASP1 SPTA1 SPTBN1 TRPC5 NUMA1 ACTN4 ACTN1 NEB OPA1 JMY CRMP1 DST SYNE2 MACF1 TRPV4 PLK1 FKBP4 | 1.01e-04 | 1099 | 131 | 19 | GO:0008092 |
| GeneOntologyMolecularFunction | microtubule plus-end binding | 3.88e-04 | 22 | 131 | 3 | GO:0051010 | |
| GeneOntologyMolecularFunction | phosphatidic acid binding | 5.05e-04 | 24 | 131 | 3 | GO:0070300 | |
| GeneOntologyMolecularFunction | histone H3K4me/H3K4me2/H3K4me3 demethylase activity | 6.30e-04 | 6 | 131 | 2 | GO:0034647 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | MYH9 MYH11 SMARCAL1 DNAH2 RNF213 ATP10B SMARCAD1 ATP13A2 DQX1 HELZ2 MACF1 ACSL5 | 7.31e-04 | 614 | 131 | 12 | GO:0140657 |
| GeneOntologyMolecularFunction | molecular carrier activity | 7.31e-04 | 108 | 131 | 5 | GO:0140104 | |
| GeneOntologyMolecularFunction | histone H3 demethylase activity | 8.02e-04 | 28 | 131 | 3 | GO:0141052 | |
| GeneOntologyMolecularFunction | oxo-acid-lyase activity | 8.78e-04 | 7 | 131 | 2 | GO:0016833 | |
| GeneOntologyMolecularFunction | transcription coactivator activity | 8.84e-04 | 303 | 131 | 8 | GO:0003713 | |
| GeneOntologyMolecularFunction | microtubule binding | 9.82e-04 | 308 | 131 | 8 | GO:0008017 | |
| GeneOntologyMolecularFunction | histone demethylase activity | 1.08e-03 | 31 | 131 | 3 | GO:0032452 | |
| GeneOntologyMolecularFunction | histone H3K4 demethylase activity | 1.17e-03 | 8 | 131 | 2 | GO:0032453 | |
| GeneOntologyMolecularFunction | protein demethylase activity | 1.19e-03 | 32 | 131 | 3 | GO:0140457 | |
| GeneOntologyMolecularFunction | magnesium ion binding | 1.24e-03 | 247 | 131 | 7 | GO:0000287 | |
| GeneOntologyBiologicalProcess | regulation of cellular component size | MYH9 DEPTOR SWAP70 SPTA1 SPTBN1 TRPC5 TSC2 POU4F2 NEB ATP13A2 CLCN3 MACF1 TRPV4 WNK3 | 5.66e-07 | 426 | 131 | 14 | GO:0032535 |
| GeneOntologyBiologicalProcess | negative regulation of cellular component organization | MYH9 TENT4B HLA-A SWAP70 CLASP1 SPTA1 B2M SPTBN1 TRPC5 TSC2 OPA1 CRMP1 ZWINT PHF2 NLGN3 PEX5 TRPV4 PLK1 FKBP4 | 2.29e-06 | 864 | 131 | 19 | GO:0051129 |
| GeneOntologyBiologicalProcess | MHC class I protein complex assembly | 4.94e-06 | 6 | 131 | 3 | GO:0002397 | |
| GeneOntologyBiologicalProcess | peptide antigen assembly with MHC class I protein complex | 4.94e-06 | 6 | 131 | 3 | GO:0002502 | |
| GeneOntologyBiologicalProcess | actin cytoskeleton organization | MYH9 MYH11 CDC42BPA SWAP70 CLASP1 CALR SPTA1 SPTBN1 ACTN4 ACTN1 NEB CDC42BPB JMY PGM5 STRIP1 TRPV4 ASB2 | 1.34e-05 | 803 | 131 | 17 | GO:0030036 |
| GeneOntologyBiologicalProcess | actin filament-based process | MYH9 MYH11 CDC42BPA SWAP70 CLASP1 CALR SPTA1 SPTBN1 ACTN4 ACTN1 NEB CDC42BPB JMY PGM5 STRIP1 SYNE2 TRPV4 ASB2 | 1.88e-05 | 912 | 131 | 18 | GO:0030029 |
| GeneOntologyBiologicalProcess | regulation of cell adhesion | MYH9 HLA-A SWAP70 CLASP1 CALR SPTA1 B2M TSC2 ACTN4 ST3GAL4 OPA1 CD160 BTN1A1 SMARCC2 MACF1 TRPV4 ALOX12 PRLR | 2.34e-05 | 927 | 131 | 18 | GO:0030155 |
| GeneOntologyBiologicalProcess | regulation of organelle organization | MYH9 SNX4 TENT4B SWAP70 CLASP1 CALR SPTA1 SPTBN1 NUMA1 TSC2 NEB ATP13A2 OPA1 ZWINT SYNE2 NCAPD2 SENP6 SMARCC2 TRPV4 PLK1 PID1 FKBP4 | 3.67e-05 | 1342 | 131 | 22 | GO:0033043 |
| GeneOntologyBiologicalProcess | regulation of anatomical structure size | MYH9 DEPTOR SWAP70 SPTA1 SPTBN1 TRPC5 TSC2 POU4F2 NEB ATP13A2 CLCN3 MACF1 TRPV4 WNK3 | 3.96e-05 | 618 | 131 | 14 | GO:0090066 |
| GeneOntologyBiologicalProcess | regulation of protein depolymerization | 5.63e-05 | 105 | 131 | 6 | GO:1901879 | |
| GeneOntologyBiologicalProcess | negative regulation of organelle organization | MYH9 TENT4B SWAP70 CLASP1 SPTA1 SPTBN1 TSC2 OPA1 ZWINT PLK1 FKBP4 | 7.96e-05 | 421 | 131 | 11 | GO:0010639 |
| GeneOntologyBiologicalProcess | peptidyl-threonine phosphorylation | 9.35e-05 | 115 | 131 | 6 | GO:0018107 | |
| GeneOntologyBiologicalProcess | regulation of cell size | 9.69e-05 | 225 | 131 | 8 | GO:0008361 | |
| GeneOntologyBiologicalProcess | negative regulation of neuron projection development | 1.04e-04 | 169 | 131 | 7 | GO:0010977 | |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | MYH9 KRT13 MYH11 SWAP70 CLASP1 SPTA1 B2M SPTBN1 NUMA1 ACTN4 ACTN1 NEB JMY PGM5 TLL2 TRPV4 FKBP4 | 1.20e-04 | 957 | 131 | 17 | GO:0097435 |
| GeneOntologyBiologicalProcess | negative regulation of cell projection organization | 1.23e-04 | 233 | 131 | 8 | GO:0031345 | |
| GeneOntologyBiologicalProcess | microtubule-based process | ATG16L1 MYH9 CDC42BPA CLASP1 TUBA1C NUMA1 DNAH2 APOB OPA1 CFAP54 DST SYNE2 SENP6 MACF1 TRPV4 SPAG17 PLK1 FKBP4 | 1.28e-04 | 1058 | 131 | 18 | GO:0007017 |
| GeneOntologyBiologicalProcess | peptidyl-threonine modification | 1.48e-04 | 125 | 131 | 6 | GO:0018210 | |
| GeneOntologyBiologicalProcess | establishment or maintenance of cell polarity | 2.41e-04 | 257 | 131 | 8 | GO:0007163 | |
| GeneOntologyBiologicalProcess | chromosome separation | 2.46e-04 | 88 | 131 | 5 | GO:0051304 | |
| GeneOntologyBiologicalProcess | negative regulation of protein depolymerization | 2.59e-04 | 89 | 131 | 5 | GO:1901880 | |
| GeneOntologyBiologicalProcess | MHC protein complex assembly | 3.06e-04 | 21 | 131 | 3 | GO:0002396 | |
| GeneOntologyBiologicalProcess | peptide antigen assembly with MHC protein complex | 3.06e-04 | 21 | 131 | 3 | GO:0002501 | |
| GeneOntologyBiologicalProcess | organelle assembly | RAB19 ATG16L1 SNX4 MYH11 CLASP1 NUMA1 DNAH2 RNF213 NEB PGM5 NLGN3 CFAP54 SYNE2 SENP6 ASB2 SPAG17 PLK1 WNK3 | 3.13e-04 | 1138 | 131 | 18 | GO:0070925 |
| GeneOntologyBiologicalProcess | protein depolymerization | 3.19e-04 | 144 | 131 | 6 | GO:0051261 | |
| GeneOntologyBiologicalProcess | regulation of protein-containing complex disassembly | 3.19e-04 | 144 | 131 | 6 | GO:0043244 | |
| GeneOntologyBiologicalProcess | regulation of cell-cell adhesion | HLA-A SWAP70 SPTA1 B2M TSC2 ST3GAL4 OPA1 CD160 BTN1A1 SMARCC2 TRPV4 ALOX12 | 3.31e-04 | 580 | 131 | 12 | GO:0022407 |
| GeneOntologyBiologicalProcess | negative regulation of actin filament depolymerization | 3.32e-04 | 52 | 131 | 4 | GO:0030835 | |
| GeneOntologyBiologicalProcess | negative regulation of protein-containing complex disassembly | 4.45e-04 | 100 | 131 | 5 | GO:0043242 | |
| GeneOntologyBiologicalProcess | cortical cytoskeleton organization | 4.73e-04 | 57 | 131 | 4 | GO:0030865 | |
| GeneOntologyCellularComponent | actomyosin | 5.63e-08 | 117 | 132 | 9 | GO:0042641 | |
| GeneOntologyCellularComponent | cortical cytoskeleton | 1.31e-07 | 129 | 132 | 9 | GO:0030863 | |
| GeneOntologyCellularComponent | actin cytoskeleton | MYH9 MYH11 CDC42BPA SWAP70 SPTA1 SPTBN1 ACTN4 ACTN1 NEB CDC42BPB PGM5 CRMP1 DST MACF1 TRPV4 ASB2 | 7.38e-07 | 576 | 132 | 16 | GO:0015629 |
| GeneOntologyCellularComponent | supramolecular fiber | MYH9 KRT13 MYH11 CLASP1 TRPC1 TUBA1C SPTBN1 NUMA1 DNAH2 ACTN4 ACTN1 CMYA5 NEB OPA1 PGM5 DST SYNE2 MACF1 TRPV4 ASB2 SPAG17 PLK1 FKBP4 | 1.25e-06 | 1179 | 132 | 23 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | MYH9 KRT13 MYH11 CLASP1 TRPC1 TUBA1C SPTBN1 NUMA1 DNAH2 ACTN4 ACTN1 CMYA5 NEB OPA1 PGM5 DST SYNE2 MACF1 TRPV4 ASB2 SPAG17 PLK1 FKBP4 | 1.40e-06 | 1187 | 132 | 23 | GO:0099081 |
| GeneOntologyCellularComponent | contractile muscle fiber | MYH11 TRPC1 SPTBN1 ACTN4 ACTN1 CMYA5 NEB PGM5 DST SYNE2 ASB2 | 2.37e-06 | 290 | 132 | 11 | GO:0043292 |
| GeneOntologyCellularComponent | sarcomere | 4.20e-06 | 249 | 132 | 10 | GO:0030017 | |
| GeneOntologyCellularComponent | contractile actin filament bundle | 5.27e-06 | 107 | 132 | 7 | GO:0097517 | |
| GeneOntologyCellularComponent | stress fiber | 5.27e-06 | 107 | 132 | 7 | GO:0001725 | |
| GeneOntologyCellularComponent | myofibril | 9.43e-06 | 273 | 132 | 10 | GO:0030016 | |
| GeneOntologyCellularComponent | actin filament bundle | 1.01e-05 | 118 | 132 | 7 | GO:0032432 | |
| GeneOntologyCellularComponent | cell cortex | MYH9 CLASP1 SPTA1 TRPC4 SPTBN1 NUMA1 ACTN4 ACTN1 DST MACF1 TRPV4 | 2.42e-05 | 371 | 132 | 11 | GO:0005938 |
| GeneOntologyCellularComponent | cortical actin cytoskeleton | 2.75e-05 | 93 | 132 | 6 | GO:0030864 | |
| GeneOntologyCellularComponent | Z disc | 4.95e-05 | 151 | 132 | 7 | GO:0030018 | |
| GeneOntologyCellularComponent | cell leading edge | MYH9 CDC42BPA SWAP70 SPTBN1 ACTN1 CDC42BPB JMY DST CLCN3 SYNE2 MACF1 TRPV4 | 7.99e-05 | 500 | 132 | 12 | GO:0031252 |
| GeneOntologyCellularComponent | MHC class I peptide loading complex | 8.51e-05 | 14 | 132 | 3 | GO:0042824 | |
| GeneOntologyCellularComponent | I band | 9.00e-05 | 166 | 132 | 7 | GO:0031674 | |
| GeneOntologyCellularComponent | focal adhesion | 9.33e-05 | 431 | 132 | 11 | GO:0005925 | |
| GeneOntologyCellularComponent | cell-substrate junction | 1.19e-04 | 443 | 132 | 11 | GO:0030055 | |
| GeneOntologyCellularComponent | condensed chromosome, centromeric region | 2.29e-04 | 193 | 132 | 7 | GO:0000779 | |
| GeneOntologyCellularComponent | costamere | 3.47e-04 | 22 | 132 | 3 | GO:0043034 | |
| GeneOntologyCellularComponent | cortical microtubule cytoskeleton | 3.91e-04 | 5 | 132 | 2 | GO:0030981 | |
| GeneOntologyCellularComponent | microtubule | CLASP1 TUBA1C NUMA1 DNAH2 OPA1 DST MACF1 TRPV4 SPAG17 PLK1 FKBP4 | 5.75e-04 | 533 | 132 | 11 | GO:0005874 |
| GeneOntologyCellularComponent | cortical granule | 5.84e-04 | 6 | 132 | 2 | GO:0060473 | |
| GeneOntologyCellularComponent | microtubule plus-end | 7.18e-04 | 28 | 132 | 3 | GO:0035371 | |
| GeneOntologyCellularComponent | anchoring junction | MYH9 CDC42BPA CLASP1 CALR TRPC4 B2M MCAM ACTN4 ACTN1 CDC42BPB PGM5 DST SYNE2 TRPV4 WNK3 | 1.29e-03 | 976 | 132 | 15 | GO:0070161 |
| GeneOntologyCellularComponent | spectrin-associated cytoskeleton | 1.38e-03 | 9 | 132 | 2 | GO:0014731 | |
| GeneOntologyCellularComponent | spectrin | 1.38e-03 | 9 | 132 | 2 | GO:0008091 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | MYH9 KRT13 CLASP1 TUBA1C NUMA1 DNAH2 ACTN1 OPA1 DST MACF1 TRPV4 SPAG17 PLK1 FKBP4 | 1.66e-03 | 899 | 132 | 14 | GO:0099513 |
| GeneOntologyCellularComponent | MHC class I protein complex | 1.72e-03 | 10 | 132 | 2 | GO:0042612 | |
| GeneOntologyCellularComponent | microtubule end | 1.77e-03 | 38 | 132 | 3 | GO:1990752 | |
| GeneOntologyCellularComponent | chromosome, centromeric region | 1.88e-03 | 276 | 132 | 7 | GO:0000775 | |
| GeneOntologyCellularComponent | cytoplasmic region | 2.07e-03 | 360 | 132 | 8 | GO:0099568 | |
| GeneOntologyCellularComponent | Golgi membrane | HLA-A B2M B3GALT6 RTN3 ST3GAL4 TVP23B RAB41 CLCN3 TVP23C TVP23A GOLGB1 DOP1A | 2.07e-03 | 721 | 132 | 12 | GO:0000139 |
| GeneOntologyCellularComponent | endosome lumen | 2.53e-03 | 43 | 132 | 3 | GO:0031904 | |
| GeneOntologyCellularComponent | cuticular plate | 2.95e-03 | 13 | 132 | 2 | GO:0032437 | |
| GeneOntologyCellularComponent | phagocytic vesicle | 3.23e-03 | 157 | 132 | 5 | GO:0045335 | |
| GeneOntologyCellularComponent | condensed chromosome | 3.40e-03 | 307 | 132 | 7 | GO:0000793 | |
| GeneOntologyCellularComponent | lamellipodium | 3.44e-03 | 230 | 132 | 6 | GO:0030027 | |
| GeneOntologyCellularComponent | cell-cell junction | MYH9 CDC42BPA TRPC4 ACTN4 ACTN1 CDC42BPB PGM5 DST TRPV4 WNK3 | 4.33e-03 | 591 | 132 | 10 | GO:0005911 |
| GeneOntologyCellularComponent | A band | 4.34e-03 | 52 | 132 | 3 | GO:0031672 | |
| GeneOntologyCellularComponent | growth cone | 4.68e-03 | 245 | 132 | 6 | GO:0030426 | |
| GeneOntologyCellularComponent | vacuolar membrane | 4.94e-03 | 507 | 132 | 9 | GO:0005774 | |
| GeneOntologyCellularComponent | endoplasmic reticulum quality control compartment | 5.06e-03 | 17 | 132 | 2 | GO:0044322 | |
| GeneOntologyCellularComponent | postsynapse | SWAP70 SPTBN1 DOCK10 RTN3 TSC2 ACTN4 ACTN1 CNIH3 CRMP1 NLGN3 DST CLCN3 SENP6 MACF1 | 5.06e-03 | 1018 | 132 | 14 | GO:0098794 |
| GeneOntologyCellularComponent | site of polarized growth | 5.46e-03 | 253 | 132 | 6 | GO:0030427 | |
| GeneOntologyCellularComponent | autophagosome membrane | 5.62e-03 | 57 | 132 | 3 | GO:0000421 | |
| GeneOntologyCellularComponent | pseudopodium | 5.67e-03 | 18 | 132 | 2 | GO:0031143 | |
| Domain | Spectrin | 2.18e-10 | 23 | 137 | 7 | PF00435 | |
| Domain | Spectrin_repeat | 1.34e-09 | 29 | 137 | 7 | IPR002017 | |
| Domain | SPEC | 2.83e-09 | 32 | 137 | 7 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 2.83e-09 | 32 | 137 | 7 | IPR018159 | |
| Domain | ACTININ_2 | 1.27e-08 | 23 | 137 | 6 | PS00020 | |
| Domain | ACTININ_1 | 1.27e-08 | 23 | 137 | 6 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 1.27e-08 | 23 | 137 | 6 | IPR001589 | |
| Domain | TRP_channel | 8.79e-07 | 11 | 137 | 4 | IPR004729 | |
| Domain | DUF846 | 1.54e-06 | 4 | 137 | 3 | PF05832 | |
| Domain | DUF846_euk | 1.54e-06 | 4 | 137 | 3 | IPR008564 | |
| Domain | TRP_2 | 7.60e-06 | 6 | 137 | 3 | PF08344 | |
| Domain | EFhand_Ca_insen | 7.60e-06 | 6 | 137 | 3 | PF08726 | |
| Domain | TRP_dom | 7.60e-06 | 6 | 137 | 3 | IPR013555 | |
| Domain | EF-hand_Ca_insen | 7.60e-06 | 6 | 137 | 3 | IPR014837 | |
| Domain | CH | 8.08e-06 | 65 | 137 | 6 | SM00033 | |
| Domain | CH | 1.24e-05 | 70 | 137 | 6 | PF00307 | |
| Domain | TRPC_channel | 1.32e-05 | 7 | 137 | 3 | IPR002153 | |
| Domain | - | 1.35e-05 | 71 | 137 | 6 | 1.10.418.10 | |
| Domain | CH | 1.59e-05 | 73 | 137 | 6 | PS50021 | |
| Domain | CH-domain | 1.86e-05 | 75 | 137 | 6 | IPR001715 | |
| Domain | KELK | 5.34e-05 | 2 | 137 | 2 | IPR031597 | |
| Domain | KELK | 5.34e-05 | 2 | 137 | 2 | PF15796 | |
| Domain | EFh | 1.66e-04 | 158 | 137 | 7 | SM00054 | |
| Domain | Lys_sp_deMease-like_dom | 3.17e-04 | 4 | 137 | 2 | IPR013637 | |
| Domain | Myotonic_dystrophy_kinase_coil | 3.17e-04 | 4 | 137 | 2 | IPR014930 | |
| Domain | PLU-1 | 3.17e-04 | 4 | 137 | 2 | PF08429 | |
| Domain | Myotonic_dystrophy_kinase_coil | 3.17e-04 | 4 | 137 | 2 | PD011252 | |
| Domain | DMPK_coil | 3.17e-04 | 4 | 137 | 2 | PF08826 | |
| Domain | EF_hand_dom | 3.18e-04 | 232 | 137 | 8 | IPR002048 | |
| Domain | zf-C5HC2 | 5.26e-04 | 5 | 137 | 2 | PF02928 | |
| Domain | Znf_C5HC2 | 5.26e-04 | 5 | 137 | 2 | IPR004198 | |
| Domain | JmjC | 6.98e-04 | 24 | 137 | 3 | PF02373 | |
| Domain | - | 7.86e-04 | 6 | 137 | 2 | 3.90.1290.10 | |
| Domain | GAR | 7.86e-04 | 6 | 137 | 2 | PS51460 | |
| Domain | GAS2 | 7.86e-04 | 6 | 137 | 2 | PF02187 | |
| Domain | - | 7.86e-04 | 6 | 137 | 2 | 3.30.920.20 | |
| Domain | GAS_dom | 7.86e-04 | 6 | 137 | 2 | IPR003108 | |
| Domain | GAS2 | 7.86e-04 | 6 | 137 | 2 | SM00243 | |
| Domain | Plectin | 1.09e-03 | 7 | 137 | 2 | PF00681 | |
| Domain | ApoL | 1.09e-03 | 7 | 137 | 2 | PF05461 | |
| Domain | Plectin_repeat | 1.09e-03 | 7 | 137 | 2 | IPR001101 | |
| Domain | ApoL | 1.09e-03 | 7 | 137 | 2 | IPR008405 | |
| Domain | PLEC | 1.09e-03 | 7 | 137 | 2 | SM00250 | |
| Domain | EF-hand-dom_pair | 1.28e-03 | 287 | 137 | 8 | IPR011992 | |
| Domain | EF_HAND_2 | 1.60e-03 | 231 | 137 | 7 | PS50222 | |
| Domain | JMJC | 1.64e-03 | 32 | 137 | 3 | PS51184 | |
| Domain | JmjC_dom | 1.64e-03 | 32 | 137 | 3 | IPR003347 | |
| Domain | JmjC | 1.79e-03 | 33 | 137 | 3 | SM00558 | |
| Domain | EF_Hand_1_Ca_BS | 1.86e-03 | 175 | 137 | 6 | IPR018247 | |
| Domain | JmjN | 2.31e-03 | 10 | 137 | 2 | SM00545 | |
| Domain | JmjN | 2.31e-03 | 10 | 137 | 2 | PF02375 | |
| Domain | JMJN | 2.31e-03 | 10 | 137 | 2 | PS51183 | |
| Domain | JmjN | 2.31e-03 | 10 | 137 | 2 | IPR003349 | |
| Domain | - | 2.38e-03 | 248 | 137 | 7 | 1.25.40.20 | |
| Domain | ANK | 2.55e-03 | 251 | 137 | 7 | SM00248 | |
| Domain | ANK_REPEAT | 2.67e-03 | 253 | 137 | 7 | PS50088 | |
| Domain | Ankyrin_rpt-contain_dom | 2.72e-03 | 254 | 137 | 7 | IPR020683 | |
| Domain | ANK_REP_REGION | 2.72e-03 | 254 | 137 | 7 | PS50297 | |
| Domain | NTP_transf_2 | 2.81e-03 | 11 | 137 | 2 | PF01909 | |
| Domain | Polymerase_NTP_transf_dom | 2.81e-03 | 11 | 137 | 2 | IPR002934 | |
| Domain | - | 3.17e-03 | 261 | 137 | 7 | 1.10.238.10 | |
| Domain | Ankyrin_rpt | 3.23e-03 | 262 | 137 | 7 | IPR002110 | |
| Domain | EF_HAND_1 | 3.97e-03 | 204 | 137 | 6 | PS00018 | |
| Domain | CNH | 4.59e-03 | 14 | 137 | 2 | SM00036 | |
| Domain | - | 5.27e-03 | 15 | 137 | 2 | 1.10.150.60 | |
| Domain | BRIGHT | 5.27e-03 | 15 | 137 | 2 | SM00501 | |
| Domain | ARID_dom | 5.27e-03 | 15 | 137 | 2 | IPR001606 | |
| Domain | ARID | 5.27e-03 | 15 | 137 | 2 | PS51011 | |
| Domain | Myosin_N | 5.27e-03 | 15 | 137 | 2 | PF02736 | |
| Domain | CNH | 5.27e-03 | 15 | 137 | 2 | PF00780 | |
| Domain | ARID | 5.27e-03 | 15 | 137 | 2 | PF01388 | |
| Domain | Myosin_N | 5.27e-03 | 15 | 137 | 2 | IPR004009 | |
| Domain | CNH | 5.27e-03 | 15 | 137 | 2 | PS50219 | |
| Domain | CNH_dom | 5.27e-03 | 15 | 137 | 2 | IPR001180 | |
| Domain | EF-hand_1 | 5.28e-03 | 152 | 137 | 5 | PF00036 | |
| Domain | PBD | 5.99e-03 | 16 | 137 | 2 | SM00285 | |
| Domain | Ank | 6.77e-03 | 228 | 137 | 6 | PF00023 | |
| Pathway | REACTOME_ROLE_OF_SECOND_MESSENGERS_IN_NETRIN_1_SIGNALING | 4.64e-05 | 10 | 105 | 3 | M27330 | |
| Pathway | REACTOME_TRP_CHANNELS | 5.19e-05 | 28 | 105 | 4 | MM14943 | |
| Pathway | REACTOME_TRP_CHANNELS | 5.19e-05 | 28 | 105 | 4 | M27241 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 6.60e-05 | 183 | 105 | 8 | M997 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES | 8.41e-05 | 12 | 105 | 3 | M47529 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | MYH9 MYH11 EMC3 CDC42BPA SWAP70 CLASP1 TUBA1C SPTBN1 MCAM DOCK10 ACTN1 CDC42BPB ZWINT DST PLK1 | 8.90e-05 | 649 | 105 | 15 | MM15690 |
| Pathway | REACTOME_STIMULI_SENSING_CHANNELS | 1.38e-04 | 106 | 105 | 6 | M27200 | |
| Pathway | BIOCARTA_RACC_PATHWAY | 1.71e-04 | 15 | 105 | 3 | M22002 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | MYH9 MYH11 EMC3 CDC42BPA SWAP70 CLASP1 TUBA1C SPTBN1 MCAM DOCK10 ACTN1 CDC42BPB ZWINT DST PLK1 | 2.77e-04 | 720 | 105 | 15 | M41838 |
| Pathway | REACTOME_ER_PHAGOSOME_PATHWAY | 3.02e-04 | 18 | 105 | 3 | MM14525 | |
| Pathway | WP_NEURODEGENERATION_WITH_BRAIN_IRON_ACCUMULATION_NBIA_SUBTYPES_PATHWAY | 3.14e-04 | 44 | 105 | 4 | M39602 | |
| Pathway | REACTOME_ASPARAGINE_N_LINKED_GLYCOSYLATION | CALR SPTA1 TUBA1C SPTBN1 ST3GAL4 CNIH3 ANKRD28 GOLGB1 MAN1B1 | 4.72e-04 | 307 | 105 | 9 | M894 |
| Pathway | REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION | 4.92e-04 | 187 | 105 | 7 | M961 | |
| Pathway | REACTOME_NEPHRIN_FAMILY_INTERACTIONS | 6.38e-04 | 23 | 105 | 3 | M913 | |
| Pubmed | MYH9 UBTD2 KRT13 MYH11 ELOA2 SPTA1 SPTBN1 NUMA1 DNAH2 ATP10B ACTN4 APOB ACTN1 ZFC3H1 NEB OGDH DST CLCN3 SYNE2 NCAPD2 SMARCC2 MACF1 SPAG17 CCDC191 GOLGB1 DOP1A | 7.71e-11 | 1442 | 137 | 26 | 35575683 | |
| Pubmed | MYH9 MYH11 CLASP1 SPTA1 TUBA1C SPTBN1 RTN3 ACTN4 ACTN1 OGDH CDC42BPB OPA1 JMY STRIP1 CRMP1 SRRT NLGN3 EPS15L1 HSPA12A NWD2 CSE1L DST TTC7B SMARCC2 MACF1 | 3.62e-10 | 1431 | 137 | 25 | 37142655 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | MYH9 MYH11 CALR SPTA1 TUBA1C SPTBN1 NUMA1 RTN3 ACTN4 ACTN1 OGDH CSE1L DST ALDH18A1 SMARCC2 MACF1 SPAG17 FKBP4 DISP1 | 4.85e-10 | 807 | 137 | 19 | 30575818 |
| Pubmed | MYH9 CALR TUBA1C SPTBN1 NUMA1 ACTN4 ACTN1 CSE1L DST SYNE2 NCAPD2 HELZ2 ALDH18A1 SMARCC2 ANKRD28 MACF1 FKBP4 | 9.52e-10 | 653 | 137 | 17 | 22586326 | |
| Pubmed | SNX4 EMC3 CDC42BPA HLA-A CALR SPTBN1 MCAM RNF213 ACTN4 CDC42BPB OPA1 PHF2 HSPA12A CSE1L TTC7B SYNE2 ALDH18A1 UBR3 ANKRD28 PLK1 FKBP4 | 1.01e-09 | 1049 | 137 | 21 | 27880917 | |
| Pubmed | MYH9 CLASP1 TRPC4 SPTBN1 NUMA1 TSC2 CDC42BPB OPA1 STRIP1 CRMP1 NLGN3 EPS15L1 DST SYNE2 PEX5 SMARCC2 ANKRD28 MACF1 WNK3 GOLGB1 | 1.41e-09 | 963 | 137 | 20 | 28671696 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | MYH9 KRT13 EMC3 CLASP1 TUBA1C SPTBN1 NUMA1 MRPS27 TSC2 ACTN4 SMARCAD1 ACTN1 OPA1 SRRT CSE1L TCERG1 SYNE2 NCAPD2 ALDH18A1 HTATSF1 SMARCC2 MACF1 GOLGB1 MAN1B1 | 1.53e-09 | 1415 | 137 | 24 | 28515276 |
| Pubmed | CLASP1 CALR TUBA1C TVP23B ACTN1 NEB CRMP1 CSE1L DST SYNE2 APOL6 MACF1 | 6.40e-09 | 322 | 137 | 12 | 26514267 | |
| Pubmed | MYH9 KRT13 MYH11 CDC42BPA SPTBN1 ACTN4 ACTN1 NEB CDC42BPB CSE1L DST TCERG1 MACF1 GOLGB1 | 8.89e-09 | 486 | 137 | 14 | 20936779 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | MYH9 TENT4B HLA-A CALR TRPC1 TUBA1C SPTBN1 NUMA1 MRPS27 RTN3 ACTN4 APOB SMARCAD1 CMYA5 OGDH OPA1 PHF2 SRRT CSE1L TCERG1 NCAPD2 ALDH18A1 FKBP4 | 8.89e-09 | 1425 | 137 | 23 | 30948266 |
| Pubmed | 1.59e-08 | 8 | 137 | 4 | 15199065 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | MYH9 CDC42BPA CLASP1 SPTBN1 MRPS27 B3GALT6 GTF2IRD1 OGDH OPA1 CRMP1 PHF2 SRRT NWD2 CSE1L DST TCERG1 HELZ2 SMARCC2 MACF1 | 5.46e-08 | 1082 | 137 | 19 | 38697112 |
| Pubmed | 5.98e-08 | 3 | 137 | 3 | 28790178 | ||
| Pubmed | Differential PI(4,5)P2 sensitivities of TRPC4, C5 homomeric and TRPC1/4, C1/5 heteromeric channels. | 5.98e-08 | 3 | 137 | 3 | 30755645 | |
| Pubmed | 5.98e-08 | 3 | 137 | 3 | 34199280 | ||
| Pubmed | 5.98e-08 | 3 | 137 | 3 | 32359120 | ||
| Pubmed | Picomolar, selective, and subtype-specific small-molecule inhibition of TRPC1/4/5 channels. | 5.98e-08 | 3 | 137 | 3 | 28325835 | |
| Pubmed | Dual action of the Gαq-PLCβ-PI(4,5)P2 pathway on TRPC1/4 and TRPC1/5 heterotetramers. | 5.98e-08 | 3 | 137 | 3 | 30108272 | |
| Pubmed | TDRD15 MYH9 TENT4B CDC42BPA TUBA1C MCAM RNF213 APOB CDC42BPB STRIP1 EPS15L1 DST PEX5 ALDH18A1 ANKRD28 GOLGB1 | 7.95e-08 | 777 | 137 | 16 | 35844135 | |
| Pubmed | KRT13 EMC3 CDC42BPA HLA-A CALR DNAJC25 TUBA1C SPTBN1 MRPS27 RTN3 SMARCAD1 ZFC3H1 OGDH CDC42BPB HSPA12A SYNE2 HTATSF1 ANKRD28 MACF1 TYW1 FKBP4 GOLGB1 | 8.96e-08 | 1487 | 137 | 22 | 33957083 | |
| Pubmed | 1.60e-07 | 13 | 137 | 4 | 22051675 | ||
| Pubmed | MYH9 HLA-A CLASP1 CALR B2M DOCK10 B3GALT6 RNF213 OAS2 ST3GAL4 OPA1 EPS15L1 CSE1L CLCN3 NCAPD2 HELZ2 GOLGB1 MAN1B1 ACSL5 | 1.78e-07 | 1168 | 137 | 19 | 19946888 | |
| Pubmed | MYH9 SWAP70 SPTBN1 NUMA1 OGDH CDC42BPB EPS15L1 DST ALDH18A1 MACF1 GOLGB1 | 2.08e-07 | 360 | 137 | 11 | 33111431 | |
| Pubmed | 2.38e-07 | 4 | 137 | 3 | 18261457 | ||
| Pubmed | NMDA receptor-dependent synaptic activation of TRPC channels in olfactory bulb granule cells. | 2.38e-07 | 4 | 137 | 3 | 22539836 | |
| Pubmed | 2.38e-07 | 4 | 137 | 3 | 32110987 | ||
| Pubmed | 2.38e-07 | 4 | 137 | 3 | 23188715 | ||
| Pubmed | MYH9 TUBA1C DOCK10 ACTN4 ACTN1 CMYA5 OPA1 SRRT CSE1L ALDH18A1 HTATSF1 WNK3 | 2.52e-07 | 451 | 137 | 12 | 36168627 | |
| Pubmed | 2.96e-07 | 225 | 137 | 9 | 12168954 | ||
| Pubmed | 4.11e-07 | 234 | 137 | 9 | 36243803 | ||
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | MYH9 CALR TUBA1C TRPC4 SPTBN1 NUMA1 ACTN4 OPA1 CSE1L DST HTATSF1 FKBP4 | 4.57e-07 | 477 | 137 | 12 | 31300519 |
| Pubmed | RAB19 MYH9 MYH11 CDC42BPA CLASP1 SMARCAL1 SPTBN1 NUMA1 MRPS27 B3GALT6 APOB CDC42BPB ITIH2 PHF2 SRRT CSE1L TCERG1 HELZ2 ALDH18A1 SMARCC2 | 4.60e-07 | 1371 | 137 | 20 | 36244648 | |
| Pubmed | MYH9 EMC3 CDC42BPA SPTBN1 MRPS27 RTN3 ACTN4 OGDH CDC42BPB OPA1 ZWINT EPS15L1 HSPA12A CSE1L SMARCC2 UBR3 ANKRD28 MACF1 | 5.86e-07 | 1139 | 137 | 18 | 36417873 | |
| Pubmed | Formation of novel TRPC channels by complex subunit interactions in embryonic brain. | 5.95e-07 | 5 | 137 | 3 | 12857742 | |
| Pubmed | Enhanced capacitative calcium entry and TRPC channel gene expression in human LES smooth muscle. | 5.95e-07 | 5 | 137 | 3 | 12736151 | |
| Pubmed | 5.95e-07 | 5 | 137 | 3 | 21263072 | ||
| Pubmed | 5.95e-07 | 5 | 137 | 3 | 20458742 | ||
| Pubmed | 5.95e-07 | 5 | 137 | 3 | 8769474 | ||
| Pubmed | MYH11 SWAP70 MRPS27 RNF213 ZFC3H1 CDC42BPB PHF2 NLGN3 HELZ2 UBR3 MACF1 DOP1A | 6.46e-07 | 493 | 137 | 12 | 15368895 | |
| Pubmed | MYH9 UBTD2 KDM5C SPTBN1 NUMA1 ACTN4 CDC42BPB DST HELZ2 MACF1 | 8.63e-07 | 332 | 137 | 10 | 37433992 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | KDM5C TUBA1C SPTBN1 NUMA1 RNF213 SMARCAD1 SRRT CSE1L TCERG1 NCAPD2 | 8.63e-07 | 332 | 137 | 10 | 32786267 |
| Pubmed | MYH9 CDC42BPA HLA-A SPTBN1 NUMA1 OPA1 EPS15L1 CSE1L DST TCERG1 NCAPD2 ALDH18A1 MACF1 GOLGB1 | 8.74e-07 | 708 | 137 | 14 | 39231216 | |
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | MYH9 EMC3 ELOA2 HLA-A CALR B2M RTN3 RNF213 OAS2 ACTN4 OGDH F13A1 SRRT RPIA TCERG1 ALDH18A1 HTATSF1 SMARCC2 MAN1B1 ACSL5 | 1.11e-06 | 1451 | 137 | 20 | 30550785 |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | ATG16L1 MYH9 SWAP70 CALR TUBA1C SPTBN1 ACTN4 SMARCAD1 ACTN1 CMYA5 CRMP1 SRRT EPS15L1 CSE1L NCAPD2 PEX5 HTATSF1 ANKRD28 MACF1 FKBP4 | 1.16e-06 | 1455 | 137 | 20 | 22863883 |
| Pubmed | 1.19e-06 | 6 | 137 | 3 | 11390792 | ||
| Pubmed | trp, a novel mammalian gene family essential for agonist-activated capacitative Ca2+ entry. | 1.19e-06 | 6 | 137 | 3 | 8646775 | |
| Pubmed | TRPC channels regulate Ca2+-signaling and short-term plasticity of fast glutamatergic synapses. | 1.19e-06 | 6 | 137 | 3 | 31536487 | |
| Pubmed | 1.19e-06 | 6 | 137 | 3 | 32414784 | ||
| Pubmed | 1.19e-06 | 6 | 137 | 3 | 29373286 | ||
| Pubmed | 1.19e-06 | 6 | 137 | 3 | 25347706 | ||
| Pubmed | 1.19e-06 | 266 | 137 | 9 | 19380743 | ||
| Pubmed | Proteomic analysis of a detergent-resistant membrane skeleton from neutrophil plasma membranes. | 1.31e-06 | 21 | 137 | 4 | 12202484 | |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | MYH9 MYH11 SWAP70 SPTBN1 NUMA1 DNAH2 ACTN4 ACTN1 TCERG1 NCAPD2 SMARCC2 MACF1 FKBP4 GOLGB1 DOP1A | 1.37e-06 | 847 | 137 | 15 | 35235311 |
| Pubmed | 1.48e-06 | 202 | 137 | 8 | 24639526 | ||
| Pubmed | 1.81e-06 | 92 | 137 | 6 | 37343697 | ||
| Pubmed | MxA, a member of the dynamin superfamily, interacts with the ankyrin-like repeat domain of TRPC. | 2.07e-06 | 7 | 137 | 3 | 15757897 | |
| Pubmed | Mechanism of stretch-induced activation of the mechanotransducer zyxin in vascular cells. | 2.07e-06 | 7 | 137 | 3 | 23233529 | |
| Pubmed | 2.07e-06 | 7 | 137 | 3 | 36592529 | ||
| Pubmed | Functional role of TRPC proteins in vivo: lessons from TRPC-deficient mouse models. | 2.07e-06 | 7 | 137 | 3 | 15336983 | |
| Pubmed | 2.07e-06 | 7 | 137 | 3 | 32350291 | ||
| Pubmed | 2.07e-06 | 7 | 137 | 3 | 38835669 | ||
| Pubmed | 2.07e-06 | 7 | 137 | 3 | 36257322 | ||
| Pubmed | MYH9 MYH11 CALR TUBA1C SPTBN1 RTN3 ACTN4 OGDH CRMP1 HSPA12A CSE1L FKBP4 | 2.09e-06 | 552 | 137 | 12 | 36293380 | |
| Pubmed | Mapping the expression of transient receptor potential channels across murine placental development. | 2.30e-06 | 24 | 137 | 4 | 33884443 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | MYH9 KRT13 TENT4B TUBA1C SPTBN1 NUMA1 MRPS27 ACTN4 ACTN1 ZFC3H1 ITIH2 SRRT CSE1L DST TCERG1 HELZ2 ALDH18A1 FKBP4 | 2.37e-06 | 1257 | 137 | 18 | 36526897 |
| Pubmed | 2.39e-06 | 54 | 137 | 5 | 22266860 | ||
| Pubmed | 2.73e-06 | 25 | 137 | 4 | 16382100 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | EMC3 HLA-A CALR TUBA1C NUMA1 ACTN4 ACTN1 SRRT CSE1L DST SYNE2 PEX5 SMARCC2 MACF1 FKBP4 GOLGB1 | 3.01e-06 | 1024 | 137 | 16 | 24711643 |
| Pubmed | WDFY4 is required for cross-presentation in response to viral and tumor antigens. | 3.01e-06 | 156 | 137 | 7 | 30409884 | |
| Pubmed | Systematic Analysis of Human Protein Phosphatase Interactions and Dynamics. | CALR TUBA1C MRPS27 ATP10B ACTN4 CDC42BPB OPA1 STRIP1 CSE1L ANKRD28 FKBP4 MAN1B1 | 3.07e-06 | 573 | 137 | 12 | 28330616 |
| Pubmed | 3.30e-06 | 8 | 137 | 3 | 25471572 | ||
| Pubmed | Subunit composition of mammalian transient receptor potential channels in living cells. | 3.30e-06 | 8 | 137 | 3 | 12032305 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | MYH9 CLASP1 TUBA1C SPTBN1 SMARCAD1 HSPA12A CSE1L NCAPD2 SMARCC2 MACF1 PLK1 GOLGB1 | 3.59e-06 | 582 | 137 | 12 | 20467437 |
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | 4.02e-06 | 231 | 137 | 8 | 16452087 | |
| Pubmed | MYH9 CDC42BPA TUBA1C SPTBN1 MRPS27 ACTN4 OGDH CDC42BPB SRRT CSE1L NCAPD2 ALDH18A1 HTATSF1 PLK1 | 4.11e-06 | 809 | 137 | 14 | 32129710 | |
| Pubmed | CDC42BPA SPTBN1 ACTN4 CMYA5 NEB CDC42BPB DST SYNE2 ZBTB40 ANKRD28 MACF1 | 4.78e-06 | 497 | 137 | 11 | 23414517 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | CLASP1 KDM5C SPTBN1 NUMA1 MRPS27 NEB OPA1 RPIA NCAPD2 ANKRD28 PLK1 | 4.78e-06 | 497 | 137 | 11 | 36774506 |
| Pubmed | 4.85e-06 | 403 | 137 | 10 | 30562941 | ||
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | MYH9 KRT13 CLASP1 NUMA1 MRPS27 CDC42BPB STRIP1 DST SYNE2 MACF1 FKBP4 | 4.87e-06 | 498 | 137 | 11 | 36634849 |
| Pubmed | Redox regulation facilitates optimal peptide selection by MHC class I during antigen processing. | 4.94e-06 | 9 | 137 | 3 | 17055437 | |
| Pubmed | Homer binds TRPC family channels and is required for gating of TRPC1 by IP3 receptors. | 4.94e-06 | 9 | 137 | 3 | 14505576 | |
| Pubmed | 4.94e-06 | 9 | 137 | 3 | 17480026 | ||
| Pubmed | 4.94e-06 | 9 | 137 | 3 | 8805302 | ||
| Pubmed | 4.94e-06 | 9 | 137 | 3 | 11290752 | ||
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | EMC3 TENT4B HLA-A CLASP1 CALR SPTBN1 MCAM RTN3 ACTN4 ACTN1 ZFC3H1 STRIP1 CSE1L NCAPD2 SMARCC2 GOLGB1 ACSL5 | 5.50e-06 | 1203 | 137 | 17 | 29180619 |
| Pubmed | MYH9 CALR TUBA1C SPTBN1 NUMA1 ACTN4 DST TCERG1 HTATSF1 SMARCC2 GOLGB1 | 5.66e-06 | 506 | 137 | 11 | 30890647 | |
| Pubmed | 6.37e-06 | 246 | 137 | 8 | 15345747 | ||
| Pubmed | 6.42e-06 | 327 | 137 | 9 | 31409639 | ||
| Pubmed | TDRD15 MYH9 CALR TUBA1C RNF213 ACTN4 ACTN1 CMYA5 NEB OPA1 CSE1L DST MACF1 FKBP4 | 6.64e-06 | 844 | 137 | 14 | 25963833 | |
| Pubmed | TENT4B CDC42BPA CLASP1 TUBA1C MRPS27 ACTN1 ZFC3H1 CDC42BPB STRIP1 PHF2 SRRT DST TCERG1 NCAPD2 HELZ2 ALDH18A1 MACF1 GOLGB1 MAN1B1 | 6.92e-06 | 1497 | 137 | 19 | 31527615 | |
| Pubmed | Network organization of the huntingtin proteomic interactome in mammalian brain. | MYH11 KDM5C SPTA1 SPTBN1 ACTN1 OGDH OPA1 CRMP1 PHF2 EPS15L1 HSPA12A DST | 6.92e-06 | 621 | 137 | 12 | 22794259 |
| Pubmed | 7.03e-06 | 10 | 137 | 3 | 27177420 | ||
| Pubmed | ER-60, a chaperone with thiol-dependent reductase activity involved in MHC class I assembly. | 7.03e-06 | 10 | 137 | 3 | 9545232 | |
| Pubmed | Heterogeneous distribution of TRPC proteins in the embryonic cortex. | 7.03e-06 | 10 | 137 | 3 | 18989690 | |
| Pubmed | Tropomodulin isoforms regulate thin filament pointed-end capping and skeletal muscle physiology. | 7.03e-06 | 10 | 137 | 3 | 20368620 | |
| Pubmed | 7.17e-06 | 250 | 137 | 8 | 33536335 | ||
| Pubmed | A neomorphic cancer cell-specific role of MAGE-A4 in trans-lesion synthesis. | 7.68e-06 | 118 | 137 | 6 | 27377895 | |
| Pubmed | RAB19 EMC3 HLA-A CALR SPTBN1 MCAM DOCK10 MRPS27 ACTN4 ACTN1 NUDT9 OGDH ALDH18A1 FKBP4 | 8.10e-06 | 859 | 137 | 14 | 31536960 | |
| Pubmed | 8.63e-06 | 33 | 137 | 4 | 19834762 | ||
| Pubmed | BGL3 lncRNA mediates retention of the BRCA1/BARD1 complex at DNA damage sites. | 1.07e-05 | 73 | 137 | 5 | 32347575 | |
| Interaction | ENKUR interactions | 9.14e-07 | 12 | 135 | 4 | int:ENKUR | |
| Interaction | AGR2 interactions | MYH9 MYH11 CALR SPTA1 TUBA1C SPTBN1 NUMA1 RTN3 ACTN4 ACTN1 OGDH CRMP1 CSE1L DST ALDH18A1 SMARCC2 MACF1 SPAG17 FKBP4 DISP1 | 4.12e-06 | 934 | 135 | 20 | int:AGR2 |
| Interaction | KCTD13 interactions | MYH9 MYH11 CLASP1 SPTA1 TUBA1C SPTBN1 RTN3 ACTN4 ACTN1 OGDH CDC42BPB OPA1 JMY STRIP1 CRMP1 SRRT NLGN3 EPS15L1 HSPA12A NWD2 CSE1L DST TTC7B SMARCC2 MACF1 | 5.40e-06 | 1394 | 135 | 25 | int:KCTD13 |
| Interaction | SIRT7 interactions | MYH9 CALR TUBA1C SPTBN1 NUMA1 ACTN4 ACTN1 CSE1L DST SYNE2 NCAPD2 HELZ2 ALDH18A1 SMARCC2 ANKRD28 MACF1 FKBP4 | 1.01e-05 | 744 | 135 | 17 | int:SIRT7 |
| Interaction | TRPC4 interactions | 1.54e-05 | 23 | 135 | 4 | int:TRPC4 | |
| Interaction | TRPC5 interactions | 1.84e-05 | 24 | 135 | 4 | int:TRPC5 | |
| Interaction | KCNA3 interactions | MYH9 CDC42BPA HLA-A SPTBN1 NUMA1 DOCK10 RNF213 OPA1 EPS15L1 CSE1L DST TCERG1 NCAPD2 SENP6 ALDH18A1 MACF1 GOLGB1 DOP1A | 2.10e-05 | 871 | 135 | 18 | int:KCNA3 |
| Interaction | EZR interactions | ATG16L1 CDC42BPA HLA-A SWAP70 CALR SPTA1 MCAM ACTN4 ACTN1 JMY DST ANKRD28 MACF1 GOLGB1 | 2.12e-05 | 553 | 135 | 14 | int:EZR |
| Interaction | MTNR1B interactions | 3.52e-05 | 135 | 135 | 7 | int:MTNR1B | |
| Interaction | SP1 interactions | ATG16L1 MYH9 MYH11 CDC42BPA NEB GTF2IRD1 CDC42BPB SRRT SENP6 SMARCC2 FKBP4 | 3.57e-05 | 365 | 135 | 11 | int:SP1 |
| Interaction | TRPC1 interactions | 4.02e-05 | 29 | 135 | 4 | int:TRPC1 | |
| Interaction | LRRC7 interactions | 4.32e-05 | 58 | 135 | 5 | int:LRRC7 | |
| Interaction | SUMO2 interactions | ATG16L1 CALR KDM5C TUBA1C SPTBN1 NUMA1 RNF213 SMARCAD1 SRRT CSE1L DST TCERG1 NCAPD2 SENP6 | 4.38e-05 | 591 | 135 | 14 | int:SUMO2 |
| Interaction | TRAF3IP1 interactions | 4.57e-05 | 96 | 135 | 6 | int:TRAF3IP1 | |
| Interaction | RHOF interactions | EMC3 CDC42BPA HLA-A B2M SPTBN1 MCAM ACTN4 ACTN1 CDC42BPB HSPA12A CSE1L TTC7B NCAPD2 MACF1 GOLGB1 | 4.63e-05 | 673 | 135 | 15 | int:RHOF |
| Interaction | RHOA interactions | ATG16L1 EMC3 CDC42BPA HLA-A TRPC1 TUBA1C B2M SPTBN1 MCAM RTN3 OGDH CDC42BPB OPA1 CRMP1 HSPA12A CSE1L SYNE2 MACF1 TYW1 UBE2Q2 GOLGB1 | 4.78e-05 | 1199 | 135 | 21 | int:RHOA |
| Interaction | TRIM33 interactions | MYH9 KDM5C ACTN4 ACTN1 NLGN3 CSE1L PEX5 ALDH18A1 SMARCC2 ANKRD28 PLK1 GOLGB1 | 5.49e-05 | 453 | 135 | 12 | int:TRIM33 |
| Interaction | DPP4 interactions | CDC42BPA HLA-A CALR SPTBN1 MCAM ACTN4 APOB ACTN1 CDC42BPB HSPA12A CSE1L GOLGB1 | 5.49e-05 | 453 | 135 | 12 | int:DPP4 |
| Interaction | CLEC4D interactions | 6.75e-05 | 261 | 135 | 9 | int:CLEC4D | |
| Interaction | LGR4 interactions | 6.95e-05 | 262 | 135 | 9 | int:LGR4 | |
| Interaction | TTLL6 interactions | 8.00e-05 | 13 | 135 | 3 | int:TTLL6 | |
| Interaction | PPP1R9B interactions | ATG16L1 MYH9 MYH11 CALR TUBA1C SPTBN1 RTN3 ACTN4 ACTN1 OGDH OPA1 CRMP1 HSPA12A ANKRD28 | 8.10e-05 | 626 | 135 | 14 | int:PPP1R9B |
| Interaction | PHLPP1 interactions | 8.42e-05 | 333 | 135 | 10 | int:PHLPP1 | |
| Interaction | USP1 interactions | 8.80e-05 | 156 | 135 | 7 | int:USP1 | |
| Interaction | ITPR3 interactions | 8.98e-05 | 211 | 135 | 8 | int:ITPR3 | |
| Interaction | ARHGAP24 interactions | MYH9 TUBA1C DOCK10 ACTN4 ACTN1 CMYA5 OPA1 SRRT CSE1L ALDH18A1 HTATSF1 WNK3 | 1.07e-04 | 486 | 135 | 12 | int:ARHGAP24 |
| Interaction | DRD2 interactions | 1.19e-04 | 114 | 135 | 6 | int:DRD2 | |
| Interaction | CLEC4E interactions | 1.36e-04 | 353 | 135 | 10 | int:CLEC4E | |
| Interaction | MYCBP2 interactions | ATG16L1 DEPTOR CLASP1 SPTBN1 ATP13A2 DST SYNE2 SMARCC2 MACF1 PLK1 | 1.42e-04 | 355 | 135 | 10 | int:MYCBP2 |
| Interaction | BGLT3 interactions | 1.48e-04 | 75 | 135 | 5 | int:BGLT3 | |
| Interaction | GJA1 interactions | ATG16L1 CDC42BPA HLA-A DNAJC25 SPTBN1 MCAM APOB ACTN1 CDC42BPB DST SYNE2 MACF1 GOLGB1 | 1.51e-04 | 583 | 135 | 13 | int:GJA1 |
| Interaction | DSCAM interactions | 1.56e-04 | 171 | 135 | 7 | int:DSCAM | |
| Interaction | PFN1 interactions | ATG16L1 MYH9 CALR SPTBN1 RTN3 JMY CRMP1 SYNE2 ANKRD28 MACF1 ASB2 GOLGB1 | 1.64e-04 | 509 | 135 | 12 | int:PFN1 |
| Interaction | CIAO2A interactions | 1.67e-04 | 173 | 135 | 7 | int:CIAO2A | |
| Interaction | RAC2 interactions | EMC3 CDC42BPA HLA-A SWAP70 B2M SPTBN1 MCAM RTN3 CDC42BPB DST SYNE2 MACF1 TYW1 GOLGB1 | 1.75e-04 | 674 | 135 | 14 | int:RAC2 |
| Interaction | CBL interactions | MYH9 HLA-A SPTA1 TUBA1C SPTBN1 RTN3 TSC2 ACTN1 CRMP1 EPS15L1 CLCN3 PLK1 | 1.87e-04 | 516 | 135 | 12 | int:CBL |
| Interaction | CYFIP1 interactions | 2.08e-04 | 303 | 135 | 9 | int:CYFIP1 | |
| Interaction | RHOV interactions | 2.37e-04 | 243 | 135 | 8 | int:RHOV | |
| Interaction | EFTUD2 interactions | MYH9 KRT13 EMC3 CLASP1 TUBA1C SPTBN1 NUMA1 MRPS27 SMARCAD1 ANKRD55 OPA1 SRRT CSE1L TCERG1 SYNE2 NCAPD2 ALDH18A1 HTATSF1 SMARCC2 MACF1 GOLGB1 MAN1B1 | 2.48e-04 | 1449 | 135 | 22 | int:EFTUD2 |
| Interaction | CIT interactions | MYH9 MYH11 CLASP1 CALR TRPC1 SPTBN1 NUMA1 MRPS27 RNF213 ACTN4 APOB ACTN1 CMYA5 PHF2 CSE1L TCERG1 SYNE2 ALDH18A1 SMARCC2 MACF1 SPAG17 PID1 | 2.50e-04 | 1450 | 135 | 22 | int:CIT |
| Interaction | PPP5D1P interactions | 2.65e-04 | 4 | 135 | 2 | int:PPP5D1P | |
| Interaction | MEX3A interactions | MYH9 UBTD2 KDM5C SPTBN1 NUMA1 ACTN4 CDC42BPB DST HELZ2 MACF1 | 2.67e-04 | 384 | 135 | 10 | int:MEX3A |
| Interaction | APC interactions | 2.96e-04 | 389 | 135 | 10 | int:APC | |
| Interaction | ANKRD44 interactions | 2.98e-04 | 48 | 135 | 4 | int:ANKRD44 | |
| Interaction | MCM2 interactions | TDRD15 MYH9 CALR TUBA1C NUMA1 RNF213 ACTN4 ACTN1 CMYA5 NEB OPA1 SRRT EPS15L1 CSE1L DST MACF1 PLK1 FKBP4 | 3.24e-04 | 1081 | 135 | 18 | int:MCM2 |
| Interaction | SNCA interactions | MYH9 KRT13 CLASP1 SPTBN1 NUMA1 CDC42BPB STRIP1 FBXL5 SRRT DST SYNE2 MACF1 PLK1 FKBP4 | 3.25e-04 | 716 | 135 | 14 | int:SNCA |
| Interaction | BSG interactions | MYH9 CLASP1 TUBA1C MCAM RNF213 ACTN4 ACTN1 OGDH ANKRD55 HSPA12A CSE1L NCAPD2 GOLGB1 | 3.26e-04 | 631 | 135 | 13 | int:BSG |
| Interaction | WDR5B interactions | 3.49e-04 | 50 | 135 | 4 | int:WDR5B | |
| Interaction | SASH1 interactions | 3.49e-04 | 50 | 135 | 4 | int:SASH1 | |
| Interaction | MECP2 interactions | MYH9 CDC42BPA CLASP1 SPTBN1 MRPS27 B3GALT6 GTF2IRD1 OGDH OPA1 CRMP1 PHF2 SRRT NWD2 CSE1L DST TCERG1 HELZ2 SMARCC2 MACF1 PLK1 | 3.63e-04 | 1287 | 135 | 20 | int:MECP2 |
| GeneFamily | Transient receptor potential cation channels | 8.95e-06 | 28 | 86 | 4 | 249 | |
| GeneFamily | Apolipoproteins | 1.30e-04 | 21 | 86 | 3 | 405 | |
| GeneFamily | Actinins | 1.33e-04 | 4 | 86 | 2 | 1112 | |
| GeneFamily | PHD finger proteins|Lysine demethylases | 1.96e-04 | 24 | 86 | 3 | 485 | |
| GeneFamily | EF-hand domain containing|Spectrins | 4.62e-04 | 7 | 86 | 2 | 1113 | |
| GeneFamily | EF-hand domain containing|Plakins | 6.15e-04 | 8 | 86 | 2 | 939 | |
| GeneFamily | EF-hand domain containing | 6.19e-04 | 219 | 86 | 6 | 863 | |
| GeneFamily | AT-rich interaction domain containing | 2.26e-03 | 15 | 86 | 2 | 418 | |
| GeneFamily | Myosin heavy chains | 2.26e-03 | 15 | 86 | 2 | 1098 | |
| GeneFamily | Ankyrin repeat domain containing | 5.96e-03 | 242 | 86 | 5 | 403 | |
| Coexpression | FAN_OVARY_CL9_PUTATIVE_APOPTOTIC_ENDOTHELIAL_CELL | HLA-A SWAP70 CALR TUBA1C B2M SPTBN1 ACTN4 ACTN1 SYNE2 ANKRD28 FKBP4 | 3.39e-06 | 365 | 136 | 11 | M41711 |
| Coexpression | HALLMARK_MITOTIC_SPINDLE | 9.84e-06 | 199 | 136 | 8 | M5893 | |
| Coexpression | GSE6092_UNSTIM_VS_IFNG_STIM_AND_B_BURGDORFERI_INF_ENDOTHELIAL_CELL_UP | 1.02e-05 | 200 | 136 | 8 | M6713 | |
| Coexpression | LAKE_ADULT_KIDNEY_C27_VASCULAR_SMOOTH_MUSCLE_CELLS_AND_PERICYTES | 1.70e-05 | 155 | 136 | 7 | M39246 | |
| Coexpression | LAKE_ADULT_KIDNEY_C26_MESANGIAL_CELLS | 3.99e-05 | 177 | 136 | 7 | M39245 | |
| Coexpression | KAAB_HEART_ATRIUM_VS_VENTRICLE_UP | 5.96e-05 | 256 | 136 | 8 | M10952 | |
| Coexpression | GSE37605_TREG_VS_TCONV_C57BL6_FOXP3_FUSION_GFP_UP | 7.58e-05 | 135 | 136 | 6 | M8793 | |
| Coexpression | GSE2770_IL12_AND_TGFB_VS_IL4_TREATED_ACT_CD4_TCELL_48H_DN | 7.60e-05 | 196 | 136 | 7 | M6129 | |
| Coexpression | GSE40685_TREG_VS_FOXP3_KO_TREG_PRECURSOR_UP | 8.36e-05 | 199 | 136 | 7 | M9306 | |
| Coexpression | GSE41176_WT_VS_TAK1_KO_UNSTIM_BCELL_DN | 8.36e-05 | 199 | 136 | 7 | M9941 | |
| Coexpression | GSE17721_CTRL_VS_GARDIQUIMOD_0.5H_BMDC_DN | 8.36e-05 | 199 | 136 | 7 | M3775 | |
| Coexpression | GSE27786_CD8_TCELL_VS_NKTCELL_DN | 8.63e-05 | 200 | 136 | 7 | M4840 | |
| Coexpression | GSE17721_CPG_VS_GARDIQUIMOD_1H_BMDC_DN | 8.63e-05 | 200 | 136 | 7 | M3880 | |
| Coexpression | GSE25123_CTRL_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_UP | 8.63e-05 | 200 | 136 | 7 | M7908 | |
| ToppCell | normal-na-Lymphocytic_T-CytoT_GZMH+-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.12e-07 | 185 | 137 | 8 | 097d628f92e13250c15b550f2fd1f4225fc07558 | |
| ToppCell | 3'_v3-bone_marrow-Hematopoietic_Erythro-Mega|bone_marrow / Manually curated celltypes from each tissue | 1.16e-07 | 186 | 137 | 8 | 9ff3c30b1728707bb8f9422941333fe3b2c430f4 | |
| ToppCell | COVID-19_Moderate-CD8+_T_activated|World / disease group, cell group and cell class | 1.67e-07 | 195 | 137 | 8 | 070c5d3bdbd4ea54a579c01c37fb99bcf823982e | |
| ToppCell | Fibroblasts-Pericytes|Fibroblasts / lung cells shred on cell class, cell subclass, sample id | 1.67e-07 | 195 | 137 | 8 | c2ebc0b33bda9b35b9ef26d69e5d2c6acfdb6ff1 | |
| ToppCell | (5)_Fibroblasts-(5)_Fibroblast-K_(Pericytes)|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.74e-07 | 196 | 137 | 8 | 541b1fcf509e362f6f48720046cb5378aaf7c591 | |
| ToppCell | COVID-19_Moderate-CD8+_T_activated|COVID-19_Moderate / disease group, cell group and cell class | 1.81e-07 | 197 | 137 | 8 | 4711ecb157e907758a5021248ae8b043d17672c6 | |
| ToppCell | healthy_donor-Lymphocytic-ILC-NK_cell|healthy_donor / Disease condition, Lineage, Cell class and subclass | 1.88e-07 | 198 | 137 | 8 | d7053a898e04478c577381085f615edaad3cdc5b | |
| ToppCell | healthy_donor-Lymphocytic-ILC|healthy_donor / Disease condition, Lineage, Cell class and subclass | 1.88e-07 | 198 | 137 | 8 | aa33be29e26f1b8facfc894413099083ae3bbb1b | |
| ToppCell | Control-Control-Lymphocyte-T/NK-CD4+_T_activated|Control / Disease, condition lineage and cell class | 1.88e-07 | 198 | 137 | 8 | ee71543559836fd59adc0da877b2ca538cba60cb | |
| ToppCell | Control-NK|Control / Disease condition and Cell class | 1.95e-07 | 199 | 137 | 8 | f3316fb97c6065286ffd22a0ad9fe7aa5b3b5650 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.03e-07 | 200 | 137 | 8 | 79e51afb57ca38aacebd0298e5e727b55c0cfff9 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.03e-07 | 200 | 137 | 8 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | normal-na-Lymphocytic_NK-T_mait-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.45e-06 | 180 | 137 | 7 | e66a8a61b3576ac37de7c559d16d4ed4f7a2fc78 | |
| ToppCell | normal-na-Lymphocytic_T-CytoT_GZMK+-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.62e-06 | 183 | 137 | 7 | 79defd22b3194dad16db55b9bdd220c09c1e6b90 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 1.93e-06 | 188 | 137 | 7 | 6d249fe92d51a19da19ec14bb2262d394255d577 | |
| ToppCell | Control-Myeloid-Macrophage_Alveolar|Control / Disease state, Lineage and Cell class | 2.00e-06 | 189 | 137 | 7 | 937e876122bc4b94372a4104e9c1a9068c232018 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 2.00e-06 | 189 | 137 | 7 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.08e-06 | 190 | 137 | 7 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | Control-Myeloid-Macrophage_Alveolar|Myeloid / Disease state, Lineage and Cell class | 2.15e-06 | 191 | 137 | 7 | a7bb8aba9c59c037d995a77928cc7b4d5cbb82b9 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-K_(Pericytes)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.30e-06 | 193 | 137 | 7 | 5260ac95a15cc43a19909badad0c7e3854da920d | |
| ToppCell | 368C-Fibroblasts-Fibroblast-K_(Pericytes)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.30e-06 | 193 | 137 | 7 | 5ec917931b438dd0e7fb03eb6af459d3ef6b84ba | |
| ToppCell | normal_Pleural_Fluid-T/NK_cells-CD8_low_T|T/NK_cells / Location, Cell class and cell subclass | 2.38e-06 | 194 | 137 | 7 | cf2480cc40f3c9be837b3934547e2ce30bd4fcd3 | |
| ToppCell | PBMC-Mild|PBMC / Compartment, Disease Groups and Clusters | 2.38e-06 | 194 | 137 | 7 | d1366b169d14011194e61d16b6b0953349febc78 | |
| ToppCell | 3'_v3-blood-Lymphocytic_NK-NK_CD16|blood / Manually curated celltypes from each tissue | 2.47e-06 | 195 | 137 | 7 | 789149fb52d9d16393e1649358515add60d37f2d | |
| ToppCell | 3'-Child09-12|3' / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.55e-06 | 196 | 137 | 7 | 1bcc4ffff51cdb6211824686c2422c43b09e24b2 | |
| ToppCell | PCW_10-12|World / Celltypes from embryonic and fetal-stage human lung | 2.64e-06 | 197 | 137 | 7 | 47fd8b0d596c5db1a722473c8efbb17a6bbe7538 | |
| ToppCell | normal_Lung-Fibroblasts-Smooth_muscle_cells|Fibroblasts / Location, Cell class and cell subclass | 2.82e-06 | 199 | 137 | 7 | d65847ceb68a560798df3f73e6f838e7c3e38a1c | |
| ToppCell | VE-CD4-antiviral_CD4|VE / Condition, Cell_class and T cell subcluster | 2.82e-06 | 199 | 137 | 7 | 056a0538ca5e825ae6195b4c76c208708a014533 | |
| ToppCell | Control-Lymphoid_T/NK-NK|Control / Disease group, lineage and cell class | 2.82e-06 | 199 | 137 | 7 | 94b2693a8378b9b2c58c6aebb2c6658d75b2e3de | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Alv_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 2.91e-06 | 200 | 137 | 7 | edb64556b3fefe3144f73b6efe23b9ffd34091d2 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.91e-06 | 200 | 137 | 7 | 89821a264e872ed53e08e9d3609d5cc5c314503e | |
| ToppCell | severe-NK|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.91e-06 | 200 | 137 | 7 | 64e8a6c36e0c654b7b2416c9f19b9058215222b1 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_2(LAMP5)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.91e-06 | 200 | 137 | 7 | e90155498397524b812c46f2412320230b445bb6 | |
| ToppCell | VE|World / Condition, Cell_class and T cell subcluster | 2.91e-06 | 200 | 137 | 7 | 8ae7cb81de3ffac5acdf3466d4b516d80cac95d3 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-CD4+_T_activated|COVID-19_Mild / Disease, condition lineage and cell class | 2.91e-06 | 200 | 137 | 7 | d9e8a0d047d4403fb7265fde7448e23a7780785c | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-T/NK-NK_activated|COVID-19_Severe / Disease, condition lineage and cell class | 2.91e-06 | 200 | 137 | 7 | 6a77f9643646bafc1157bf1fc1e4c614860ee642 | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 2.91e-06 | 200 | 137 | 7 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | Sepsis-Bac-SEP-Lymphocyte-T/NK-NK|Bac-SEP / Disease, condition lineage and cell class | 2.91e-06 | 200 | 137 | 7 | 394ec91eb3eafde313d67abc986095799ab4e6ac | |
| ToppCell | LPS-IL1RA-Endothelial-Epi-like-Alv_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.41e-06 | 138 | 137 | 6 | 5f8ac8f67e34a7cf560099208e6884102532391e | |
| ToppCell | BLOOD--(0)_NK_cell-(0)_NK_cells_(CD56dim-like)|(0)_NK_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 5.87e-06 | 145 | 137 | 6 | 6dd81d53d006fcc206a10969374a11c372f92133 | |
| ToppCell | Entopeduncular-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Gkn3_(Gkn3)--|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.02e-05 | 93 | 137 | 5 | 38a075f06001a2fd1ec77fc301a08a87618a2440 | |
| ToppCell | Entopeduncular-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Gkn3_(Gkn3)-|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.02e-05 | 93 | 137 | 5 | a0117b12889d9c48294a7ccea4284d00c087889f | |
| ToppCell | Entopeduncular-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Gkn3_(Gkn3)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.02e-05 | 93 | 137 | 5 | b3e057132633b25bd4f8ff2c0aa203ade0f3ba4c | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-mature_alpha-beta_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-05 | 162 | 137 | 6 | b5b2cdbcc5bbfab52cc7d8a5504d34bb2e73771a | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-BM_CD8_+_CD4_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-05 | 162 | 137 | 6 | 4f9cf67b4b00b1cf78eeb9be1c701d535021a61d | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.15e-05 | 163 | 137 | 6 | e526104a3a574ee860078ce7c049e7fec9443f37 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.31e-05 | 167 | 137 | 6 | ced6ed9b412739c6ced622523347c10295edbf53 | |
| ToppCell | Substantia_nigra-Endothelial-MURAL|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.36e-05 | 168 | 137 | 6 | 271a81c59a9a75bac6107c68fead03e7f35bc192 | |
| ToppCell | Substantia_nigra-Endothelial-MURAL-M1(Rgs5Acta2)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.36e-05 | 168 | 137 | 6 | b220e732eb7b204fc263a9f2e8ddae6bf9fa98f4 | |
| ToppCell | COVID-19_Mild-PLT_3|COVID-19_Mild / Disease Group and Platelet Clusters | 1.45e-05 | 170 | 137 | 6 | 5ac1252ae3c026a506cfe26e3d119276fe364661 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.45e-05 | 170 | 137 | 6 | 5570c0e825bca77613bf0ebde620cf744fa1cb84 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 1.50e-05 | 171 | 137 | 6 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.50e-05 | 171 | 137 | 6 | bdd30100b74e012eec3090799c22635aa57fa91d | |
| ToppCell | facs-BAT-Fat-3m-Myeloid-nan|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.55e-05 | 172 | 137 | 6 | 5f18c3f8eb8b7928901eede44c9b84b3c5efa1a9 | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-mature_NK_T_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.66e-05 | 174 | 137 | 6 | 5c69447261c5aa309a24882656da90655728d637 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS-Exc_L5-6_THEMIS_GPR21|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.77e-05 | 176 | 137 | 6 | 03d194c9814e12802cd932afade69e868814cb78 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.77e-05 | 176 | 137 | 6 | de746cdf2c777eec88cb03863e128e97ad6e8fb0 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.83e-05 | 177 | 137 | 6 | d3e6c768b88b7906f3c7fdd00ba20842212c14b1 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.83e-05 | 177 | 137 | 6 | f8f101c772c043636bedd6b2ec81409b1d2599bf | |
| ToppCell | Severe-CD4+_T_activated|Severe / Disease group and Cell class | 1.83e-05 | 177 | 137 | 6 | a08f170f1143fcdd7d0842a54d9b807a4548f8b7 | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-NK_activated|COVID-19_Mild / Disease group, lineage and cell class | 1.83e-05 | 177 | 137 | 6 | 6978a22fef40c8b455342373abe7593f5ede0fa4 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.83e-05 | 177 | 137 | 6 | 936ab2b180a052387124f68d0c7f41c0b164e748 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.83e-05 | 177 | 137 | 6 | d5aeda113afaa2425874394610344570c9078478 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS-Exc_L5-6_THEMIS_THTPA|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.89e-05 | 178 | 137 | 6 | e4e11e4940c911c17806200c25096928153c684d | |
| ToppCell | Severe-CD4+_T_activated|World / Disease group and Cell class | 1.89e-05 | 178 | 137 | 6 | ef6111238703579a34bd6948bd9d4ca6b7e16063 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.01e-05 | 180 | 137 | 6 | 7a9aa96fb8035020640cc7d3df0c41c730516c6f | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.07e-05 | 181 | 137 | 6 | beb2771820956be8b190c0088ae3c4efdb53c897 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.14e-05 | 182 | 137 | 6 | 7b86703559438e2d5ef3dad963ee0d772513f313 | |
| ToppCell | COVID-19_Mild-gd_T|COVID-19_Mild / Disease condition and Cell class | 2.20e-05 | 183 | 137 | 6 | f593a89b0aa8fffdfa403769916facfd30358521 | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 2.20e-05 | 183 | 137 | 6 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | 3'_v3-lymph-node_spleen-Hematopoietic_Erythro-Mega-Erythrocytic_early|lymph-node_spleen / Manually curated celltypes from each tissue | 2.20e-05 | 183 | 137 | 6 | 0d56e16d4868c752c7557acec212029eb469ed05 | |
| ToppCell | 3'_v3-bone_marrow-Hematopoietic_Erythro-Mega-Erythrocytic_early|bone_marrow / Manually curated celltypes from each tissue | 2.20e-05 | 183 | 137 | 6 | d43ba3fbbd9132125fa2b7ea0891a2c577974f14 | |
| ToppCell | myeloid-Dendritic_cell-Plasmacytoid_dendritic_cell|World / Lineage, cell class and subclass | 2.27e-05 | 184 | 137 | 6 | 11619778bc773ecd1a9867330be04deaf324f31e | |
| ToppCell | COPD-Myeloid-Macrophage_Alveolar|World / Disease state, Lineage and Cell class | 2.27e-05 | 184 | 137 | 6 | 7fd0b227c3750ffb80e41e92c60fcce46656be14 | |
| ToppCell | Control-Myeloid-Macrophage_Alveolar|World / Disease state, Lineage and Cell class | 2.34e-05 | 185 | 137 | 6 | 85cb81759589a26d83676cffbf2bc37399683c10 | |
| ToppCell | normal-na-Lymphocytic_NK-NK_dim-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 2.34e-05 | 185 | 137 | 6 | b1a8a8c4d0fc7605eabc17dcb6bd9e8ab4fd578c | |
| ToppCell | PBMC-Mild-Hematopoietic-Platelet-Platelet-plt_3|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.34e-05 | 185 | 137 | 6 | 0a2c8ce92a257d0ec5bcc8efa22792d53752c665 | |
| ToppCell | COVID-19_Moderate-NK_activated|World / disease group, cell group and cell class | 2.42e-05 | 186 | 137 | 6 | ff8f32f69516bf785224fa12f8139a95359b0279 | |
| ToppCell | PBMC-Mild-Hematopoietic-Platelet-Platelet-plt_3|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.42e-05 | 186 | 137 | 6 | 4a9b5b3a56229629161d5404db2b8dd76e10cf4b | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 2.42e-05 | 186 | 137 | 6 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | 10x5'-Liver-Myeloid_Dendritic-DC1|Liver / Manually curated celltypes from each tissue | 2.42e-05 | 186 | 137 | 6 | e823529ffd06352c6bdec102f221fdf27f7c7369 | |
| ToppCell | T_cells-GZMK+_CD8+_T_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 2.64e-05 | 189 | 137 | 6 | e2ca075aedf7c370ab4ede6272254ffd06cbcdec | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.72e-05 | 190 | 137 | 6 | 91ba66d4b56c59523485b17738e93f14bb00afa4 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.72e-05 | 190 | 137 | 6 | 562ee3b025c29edf07b8b344323edb49d82f1c7e | |
| ToppCell | IPF-Myeloid-Macrophage_Alveolar|Myeloid / Disease state, Lineage and Cell class | 2.72e-05 | 190 | 137 | 6 | 2592765016f291565697265800a232b2edef3792 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.72e-05 | 190 | 137 | 6 | f5fb989afabb49d64d91324570cd8c80a4b9e67d | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.80e-05 | 191 | 137 | 6 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 2.80e-05 | 191 | 137 | 6 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.80e-05 | 191 | 137 | 6 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.89e-05 | 192 | 137 | 6 | f6ec683b2133b3095a1fcc06ca8605cf38f774b5 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-CytoT_GZMH+-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.89e-05 | 192 | 137 | 6 | fdc741e1846cfd8ed741b160e3c611c310c5d36d | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.89e-05 | 192 | 137 | 6 | 690b3d17c481159bc96b8bc7f6a66b51343ee858 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-CytoT_GZMK+-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.89e-05 | 192 | 137 | 6 | ed1fb700d3e8f00495727d61e164fc0b70274fd0 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-CytoT_GZMK+|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.89e-05 | 192 | 137 | 6 | 6779b0294bb058e748e22b795b6a381c4add37e9 | |
| ToppCell | Bac-SEP-Lymphocyte-T_NK-NK|Bac-SEP / Disease, Lineage and Cell Type | 2.97e-05 | 193 | 137 | 6 | 8aa4ed2b11c6189d86e7de6bc68782fd156a37fb | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.97e-05 | 193 | 137 | 6 | fce4f805e53669acb4c188f87ac7d84408c0c218 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.97e-05 | 193 | 137 | 6 | 6e1498153a7766c03fddbda1701dbf1596d21736 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_NK|bone_marrow / Manually curated celltypes from each tissue | 2.97e-05 | 193 | 137 | 6 | e790ab76c12f74a13936c231076f1e397283efb3 | |
| ToppCell | normal-na-Lymphocytic_T-CytoT_GZMH+-female|normal / PBMC cell types (v2) per disease, treatment status, and sex | 2.97e-05 | 193 | 137 | 6 | 3184a5f454e3ac5a81f6bacf9bd8f07d9d448fba | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.97e-05 | 193 | 137 | 6 | 0256e8fe4a47f2e2a43ef9d19bfc047d20806d69 | |
| Computational | Actin cytoskeleton binding. | 2.98e-06 | 30 | 83 | 5 | MODULE_524 | |
| Computational | Genes in the cancer module 419. | 5.67e-06 | 34 | 83 | 5 | MODULE_419 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 3.92e-05 | 50 | 83 | 5 | GAVISH_3CA_MALIGNANT_METAPROGRAM_4_CHROMATIN | |
| Computational | Neighborhood of BUB1B | 5.38e-04 | 49 | 83 | 4 | GNF2_BUB1B | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 5.38e-04 | 49 | 83 | 4 | GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CHROMATIN | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 5.81e-04 | 50 | 83 | 4 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_4 | |
| Drug | 3-Acetylcoumarin [3949-36-8]; Up 200; 21.2uM; MCF7; HT_HG-U133A | 3.00e-06 | 196 | 137 | 9 | 5259_UP | |
| Drug | Hydroflumethiazide [135-09-1]; Down 200; 12uM; MCF7; HT_HG-U133A | KRT13 CDC42BPA TRPC1 MAP3K12 CDC42BPB OPA1 SRRT ZBTB40 DOP1A | 3.12e-06 | 197 | 137 | 9 | 7019_DN |
| Drug | Articaine hydrochloride [23964-57-0]; Up 200; 12.4uM; HL60; HT_HG-U133A | 3.12e-06 | 197 | 137 | 9 | 3138_UP | |
| Drug | $l^{1}-borane | 6.59e-06 | 44 | 137 | 5 | CID006397184 | |
| Drug | Coomassie blue | 1.79e-05 | 135 | 137 | 7 | CID000019731 | |
| Drug | 2-propylpentanoic acid; Down 200; 1000uM; HL60; HT_HG-U133A | 2.03e-05 | 190 | 137 | 8 | 1150_DN | |
| Drug | ST021200; Up 200; 10uM; PC3; HT_HG-U133A | 2.44e-05 | 195 | 137 | 8 | 7559_UP | |
| Drug | Papaverine hydrochloride [61-25-6]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 2.44e-05 | 195 | 137 | 8 | 6245_UP | |
| Drug | Cefaclor [70356-03-5]; Down 200; 10.4uM; MCF7; HT_HG-U133A | 2.72e-05 | 198 | 137 | 8 | 4967_DN | |
| Drug | Tribenoside [10310-32-4]; Up 200; 8.4uM; PC3; HT_HG-U133A | 2.72e-05 | 198 | 137 | 8 | 6328_UP | |
| Disease | cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement | 4.04e-06 | 144 | 132 | 7 | EFO_0004611, EFO_0020943 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 5.77e-06 | 152 | 132 | 7 | DOID:0060041 (implicated_via_orthology) | |
| Disease | cerebral cavernous malformation (implicated_via_orthology) | 1.41e-05 | 11 | 132 | 3 | DOID:0060669 (implicated_via_orthology) | |
| Disease | nicotine dependence (implicated_via_orthology) | 1.87e-05 | 12 | 132 | 3 | DOID:0050742 (implicated_via_orthology) | |
| Disease | mean platelet volume | MYH9 MYH11 SPTA1 TUBA1C SPTBN1 NUMA1 DOCK10 ACTN4 ST3GAL4 ACTN1 CDC42BPB SYNE2 ANKRD28 ALOX12 ACSL5 | 5.39e-05 | 1020 | 132 | 15 | EFO_0004584 |
| Disease | very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 6.60e-05 | 222 | 132 | 7 | EFO_0008317, EFO_0020943 | |
| Disease | cholesteryl esters to total lipids in small VLDL percentage | 6.94e-05 | 49 | 132 | 4 | EFO_0022256 | |
| Disease | syndromic X-linked intellectual disability Claes-Jensen type (implicated_via_orthology) | 1.18e-04 | 4 | 132 | 2 | DOID:0060809 (implicated_via_orthology) | |
| Disease | very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 1.93e-04 | 264 | 132 | 7 | EFO_0008317, EFO_0020944 | |
| Disease | 3-methylcytidine measurement | 1.97e-04 | 5 | 132 | 2 | EFO_0800633 | |
| Disease | focal segmental glomerulosclerosis 1 (implicated_via_orthology) | 1.97e-04 | 5 | 132 | 2 | DOID:0111128 (implicated_via_orthology) | |
| Disease | Moyamoya disease (is_implicated_in) | 1.97e-04 | 5 | 132 | 2 | DOID:13099 (is_implicated_in) | |
| Disease | cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 2.18e-04 | 121 | 132 | 5 | EFO_0008595, EFO_0020943 | |
| Disease | low density lipoprotein cholesterol measurement, physical activity | 2.22e-04 | 66 | 132 | 4 | EFO_0003940, EFO_0004611 | |
| Disease | docosahexaenoic acid measurement | 2.73e-04 | 127 | 132 | 5 | EFO_0007761 | |
| Disease | phosphatidylcholine measurement | 3.01e-04 | 284 | 132 | 7 | EFO_0010226 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 3.48e-04 | 291 | 132 | 7 | EFO_0008317, EFO_0020946 | |
| Disease | Large cell carcinoma of lung | 3.95e-04 | 32 | 132 | 3 | C0345958 | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 5.01e-04 | 145 | 132 | 5 | DOID:1289 (implicated_via_orthology) | |
| Disease | triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | 5.42e-04 | 225 | 132 | 6 | EFO_0008317, EFO_0020947 | |
| Disease | esterified cholesterol measurement, intermediate density lipoprotein measurement | 5.46e-04 | 8 | 132 | 2 | EFO_0008589, EFO_0008595 | |
| Disease | response to anticonvulsant | 5.85e-04 | 85 | 132 | 4 | GO_0036277 | |
| Disease | free cholesterol to total lipids in large VLDL percentage | 6.08e-04 | 37 | 132 | 3 | EFO_0022281 | |
| Disease | ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2 measurement | 7.00e-04 | 9 | 132 | 2 | EFO_0008014 | |
| Disease | free cholesterol in medium LDL measurement | 7.66e-04 | 40 | 132 | 3 | EFO_0022268 | |
| Disease | kidney disease (implicated_via_orthology) | 8.24e-04 | 41 | 132 | 3 | DOID:557 (implicated_via_orthology) | |
| Disease | triglycerides in large LDL measurement | 9.47e-04 | 43 | 132 | 3 | EFO_0022319 | |
| Disease | mean reticulocyte volume | MYH9 HLA-A SWAP70 CLASP1 SPTA1 DNAH2 NEB HELZ2 ZBTB40 PLK1 GOLGB1 | 9.54e-04 | 799 | 132 | 11 | EFO_0010701 |
| Disease | concentration of large LDL particles measurement | 1.01e-03 | 44 | 132 | 3 | EFO_0022160 | |
| Disease | cholesterol in medium VLDL measurement | 1.01e-03 | 44 | 132 | 3 | EFO_0022225 | |
| Disease | phospholipids in medium LDL measurement | 1.39e-03 | 49 | 132 | 3 | EFO_0022183 | |
| Disease | free cholesterol in LDL measurement | 1.47e-03 | 50 | 132 | 3 | EFO_0022266 | |
| Disease | Paranoid Schizophrenia | 1.50e-03 | 13 | 132 | 2 | C0036349 | |
| Disease | free cholesterol in large LDL measurement | 1.56e-03 | 51 | 132 | 3 | EFO_0022176 | |
| Disease | phospholipids in IDL measurement | 1.65e-03 | 52 | 132 | 3 | EFO_0022164 | |
| Disease | total lipids in LDL measurement | 1.65e-03 | 52 | 132 | 3 | EFO_0022308 | |
| Disease | phospholipids in large LDL measurement | 1.74e-03 | 53 | 132 | 3 | EFO_0022174 | |
| Disease | free cholesterol in small LDL measurement | 1.74e-03 | 53 | 132 | 3 | EFO_0022271 | |
| Disease | esterified cholesterol measurement, low density lipoprotein cholesterol measurement | 1.74e-03 | 14 | 132 | 2 | EFO_0004611, EFO_0008589 | |
| Disease | omega-3 polyunsaturated fatty acid measurement | 1.98e-03 | 118 | 132 | 4 | EFO_0010119 | |
| Disease | low density lipoprotein triglyceride measurement | 2.01e-03 | 15 | 132 | 2 | EFO_0009946 | |
| Disease | response to statin, LDL cholesterol change measurement | 2.01e-03 | 15 | 132 | 2 | EFO_0007804, GO_0036273 | |
| Disease | triglycerides in LDL measurement | 2.04e-03 | 56 | 132 | 3 | EFO_0022320 | |
| Disease | alkaline phosphatase measurement | TDRD15 ATG16L1 SPTBN1 TSC2 APOB ST3GAL4 CRMP1 SRRT NWD2 ZBTB40 MACF1 GOLGB1 | 2.05e-03 | 1015 | 132 | 12 | EFO_0004533 |
| Disease | low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 2.10e-03 | 200 | 132 | 5 | EFO_0004611, EFO_0020945 | |
| Disease | total lipids in large LDL | 2.15e-03 | 57 | 132 | 3 | EFO_0022163 | |
| Disease | cholesterol in large LDL measurement | 2.15e-03 | 57 | 132 | 3 | EFO_0021901 | |
| Disease | platelet component distribution width | SWAP70 SPTA1 TUBA1C DOCK10 ST3GAL4 ACTN1 JMY METTL24 ANKRD28 MACF1 | 2.15e-03 | 755 | 132 | 10 | EFO_0007984 |
| Disease | cholesterol in IDL measurement | 2.26e-03 | 58 | 132 | 3 | EFO_0021899 | |
| Disease | phospholipids in LDL measurement | 2.26e-03 | 58 | 132 | 3 | EFO_0022294 | |
| Disease | syndromic intellectual disability (implicated_via_orthology) | 2.29e-03 | 16 | 132 | 2 | DOID:0050888 (implicated_via_orthology) | |
| Disease | phospholipids in small LDL measurement | 2.37e-03 | 59 | 132 | 3 | EFO_0022297 | |
| Disease | total lipids in IDL | 2.49e-03 | 60 | 132 | 3 | EFO_0022161 | |
| Disease | cholesterol to total lipids in chylomicrons and extremely large VLDL percentage | 2.58e-03 | 17 | 132 | 2 | EFO_0022232 | |
| Disease | free cholesterol in IDL measurement | 2.61e-03 | 61 | 132 | 3 | EFO_0022181 | |
| Disease | Polyarthritis, Juvenile, Rheumatoid Factor Positive | 2.89e-03 | 131 | 132 | 4 | C4704862 | |
| Disease | Polyarthritis, Juvenile, Rheumatoid Factor Negative | 2.89e-03 | 131 | 132 | 4 | C4552091 | |
| Disease | Juvenile arthritis | 2.89e-03 | 131 | 132 | 4 | C3495559 | |
| Disease | Juvenile psoriatic arthritis | 2.89e-03 | 131 | 132 | 4 | C3714758 | |
| Disease | very low density lipoprotein cholesterol measurement, esterified cholesterol measurement | 2.90e-03 | 18 | 132 | 2 | EFO_0008317, EFO_0008589 | |
| Disease | language measurement | 3.14e-03 | 134 | 132 | 4 | EFO_0007797 | |
| Disease | Juvenile-Onset Still Disease | 3.22e-03 | 135 | 132 | 4 | C0087031 | |
| Disease | Malignant Glioma | 3.85e-03 | 70 | 132 | 3 | C0555198 | |
| Disease | mixed gliomas | 3.85e-03 | 70 | 132 | 3 | C0259783 | |
| Disease | Antimigraine preparation use measurement | 3.94e-03 | 21 | 132 | 2 | EFO_0009939 | |
| Disease | proprotein convertase subtilisin/kexin type 9 measurement | 4.33e-03 | 22 | 132 | 2 | EFO_0009312 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 4.47e-03 | 148 | 132 | 4 | C0279702 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| IEKVEHSDLSFSKDW | 66 | P61769 | |
| EKKSHLASIFEDDTW | 411 | P0CF97 | |
| EIHFRDDDKWSCTLK | 41 | Q96M60 | |
| SAEAHWAVRVEEKAK | 116 | Q9UBC2 | |
| AWLDEHVAFEFVLKA | 141 | Q96L58 | |
| DDIFRKPDVLHTWKE | 1946 | Q96N23 | |
| AEKFRQKASIHEAWT | 396 | P12814 | |
| ASAEHLELRWFRKKV | 56 | Q13410 | |
| HLKILLTSDEAWKRF | 51 | Q9BPW4 | |
| WKHLKEGARTKFAEE | 256 | Q9BWW8 | |
| VWHKKEEAEGFVVFL | 46 | O95971 | |
| SRLKEHIDSFEDWAV | 571 | Q96Q27 | |
| HIDSFEDWAVIKEKA | 576 | Q96Q27 | |
| HFDKKIRFWDIRSES | 466 | Q676U5 | |
| EKFRQKASIHEAWTD | 416 | O43707 | |
| AAAKLREIEQSWKHE | 391 | Q96L96 | |
| INAFDKKDRRAIHWA | 166 | O15084 | |
| EKTEFFKHVALTLWD | 866 | Q5JWR5 | |
| VDKDFKTALHWAVQS | 191 | Q3KP44 | |
| KYADEQAKSHRDDRW | 256 | Q96F81 | |
| EREKREVDWNFHKDS | 276 | Q96F81 | |
| KKVVSEEDFRRWASF | 841 | O94823 | |
| IKWAEELIAAFKEHQ | 291 | Q8N0X4 | |
| DTGLWKVAEKFRAKH | 1216 | Q9ULI1 | |
| KCDLWEKRHVLFEDA | 131 | A4D1S5 | |
| INSFKETDKWVEHVR | 116 | Q5JT25 | |
| KQSVEEIVRDHWAKF | 411 | Q15124 | |
| LWTLEEALRKHKVAD | 191 | Q8NDF8 | |
| HVGDFARDLAARWKK | 61 | Q8IYF1 | |
| RRHKTLSETDEKFWA | 126 | Q5VXI9 | |
| FDEREKHKFVFIVAW | 21 | Q8N9B5 | |
| KDKHADPDFTRKLWA | 571 | P19823 | |
| DFDWHKEKADQLVER | 1256 | Q03001 | |
| EEFLHKLKSFSDWVS | 3516 | Q03001 | |
| DARKRAKQFHEAWSK | 6701 | Q03001 | |
| HKLKIRAESFDTWAN | 751 | Q9BY66 | |
| DAEEWFHTKSAELNK | 291 | P13646 | |
| KAWDRISKDEHQDLV | 176 | Q9NX04 | |
| IELWKKHTLAREDVF | 116 | Q7Z2X4 | |
| SHDLIQKWEEKSREF | 271 | Q9Y5K3 | |
| QFIKLVAEKRDAHWS | 326 | Q9BW91 | |
| RAKSAIESDVDFWDK | 276 | P50542 | |
| EEKEFHQRRWSEDKS | 731 | Q96LU7 | |
| AADAELAWVAETKRK | 1806 | O94854 | |
| VHLFKERWDTNKVDH | 51 | P00488 | |
| IKAHAAEWKANVTAE | 336 | P57789 | |
| HQSSDKFVSELWKDV | 601 | P35579 | |
| VEHALRKSNVDFVKW | 421 | O43301 | |
| FHEEKRLDFEWTLKA | 166 | P18054 | |
| AKKESVAHWEAQIAE | 806 | Q9Y5S2 | |
| HEQLKAFWREKEEEL | 436 | P29728 | |
| DARKVVVTHWLADFS | 316 | Q8TE96 | |
| RIYKHWDFNVIDKDT | 256 | Q6P4A8 | |
| KFLQDHKEFESWLER | 3886 | Q9UPN3 | |
| HKEFESWLERSEKEL | 3891 | Q9UPN3 | |
| LDDARKRAKQFHEAW | 6546 | Q9UPN3 | |
| DHWKALAFRLEEEQK | 106 | Q9UKM7 | |
| EFEEARKWVSKKLHF | 306 | Q9UKM7 | |
| KWLLRGKDHVVSDFS | 761 | P54886 | |
| EKRKAESGWFHVEED | 116 | O43719 | |
| EESIKRHKWNDFAED | 706 | O60313 | |
| IHTKANRFEEVAWSK | 581 | Q9NZ94 | |
| VCKVAAEWRSTFHKD | 486 | Q02218 | |
| EDHQKETFLKRELWI | 301 | Q9H1X3 | |
| VSKRVAWHYDEEKIE | 1161 | P04114 | |
| AWKDTAQLHKSEEAV | 141 | Q9NQ11 | |
| DHVIWKYKDALEETR | 1036 | Q96BY6 | |
| SKHLAWSEAEKEIKF | 1431 | Q8N3K9 | |
| DSVEHWIKRVEKASE | 36 | Q8NCU4 | |
| AKELIDWLIEHKEAS | 66 | Q8TB45 | |
| RWIESKHKSDFGKFV | 36 | P27797 | |
| IRHDSFWDKLIFAKI | 391 | Q9ULC5 | |
| ITKRKWEAAHEAEQL | 166 | P04439 | |
| KSQAEWREEVKLHFE | 381 | Q12852 | |
| KAFKTEWEALELTDH | 216 | Q9P0I2 | |
| KNRKDESRAFHEWDE | 276 | Q9UKA1 | |
| ELHLKSFEKAKESWE | 246 | Q02790 | |
| KVLWEARKFELDRHE | 2321 | Q9BYK8 | |
| ILFSIVHDKSEKWDA | 326 | Q9UHL9 | |
| VHDKSEKWDAFIKET | 331 | Q9UHL9 | |
| RWEHDKDPESFFKVL | 291 | Q4AE62 | |
| SRFVKAFEKDVDHWE | 1416 | Q9P225 | |
| RKWVEVFKACDEDHK | 21 | Q9BUY7 | |
| LLTSFEKWHEAADTK | 116 | Q14194 | |
| DHSKAEDEWKAQVAR | 1201 | Q14980 | |
| DWFSVHKEKRTLIFR | 61 | P43121 | |
| HKIDVLKADLESAEW | 261 | Q5JXM2 | |
| KFDRVHKWSEVNTAI | 261 | P49247 | |
| SSAYVDSHKWEAREK | 31 | Q92552 | |
| DFSVHDLIFWRDVKK | 841 | O95197 | |
| EKRAEFVWHKLSADN | 131 | O95219 | |
| EWKKDHISRAFAVQF | 186 | Q96IW2 | |
| FRSWTKKQALAEHED | 406 | O75151 | |
| RLDWKLAAEEAKKHS | 491 | Q86VL8 | |
| FDKQELREVLKEHEW | 266 | Q9H4L7 | |
| DWHKFIEEKEFLARL | 521 | Q8WXH0 | |
| AKGKHWSEEAKIFFR | 1856 | B5MCY1 | |
| AWLEEAEKSHREKLT | 321 | Q12837 | |
| DVKTRKWSFLLEEHS | 366 | Q9NZC9 | |
| FEEDFRIHVTDKKWT | 101 | Q5VSL9 | |
| NESHKSEFIELRKWL | 26 | Q9NVD3 | |
| DFHWIETILSDKKRV | 196 | Q11206 | |
| AKKWDFLRDLGHVET | 381 | Q8IZU2 | |
| DLADKKESVAHWEAQ | 806 | Q5VT25 | |
| KVHAKWILDTDTFNE | 236 | Q8TAQ2 | |
| SLKAWKEEQHRLAEE | 936 | Q6Q759 | |
| DINKAWERLEKAEHE | 391 | Q01082 | |
| IKRHEAFEKSAATWD | 2056 | Q01082 | |
| DFFLAHKDEEWFRSK | 186 | Q9BXP5 | |
| KARTKAAHGFDWEEE | 151 | Q15021 | |
| KIREILSDDKHDWEQ | 326 | Q7Z460 | |
| DDFHTIDWVREKCKD | 86 | P51790 | |
| WHIIAFDELRTDFKS | 26 | Q8TBE1 | |
| SDKFVADLWKDVDRI | 611 | P35749 | |
| LIANHEDKEWKFARA | 651 | P48995 | |
| EHFLDSWKRFVTQKR | 1681 | Q63HN8 | |
| WKELKATYREHVEAI | 96 | O95229 | |
| IFDKNHERFRIVSWK | 16 | Q8WVN8 | |
| RHEFKSNELWTEIKL | 161 | P55060 | |
| IDEDGKSHWVFESRK | 96 | Q96ET8 | |
| KSHWVFESRKESSQE | 101 | Q96ET8 | |
| SAFSTWEKELHKIVF | 676 | O14776 | |
| TIKKSRDELVHKWFD | 241 | Q5T4T6 | |
| HKWFDDEVIAEAFKE | 251 | Q5T4T6 | |
| GRKEIWDALKAAAHA | 66 | Q8WUN7 | |
| FAKAKATWETERAEL | 771 | O94964 | |
| SWKETRSEKIHDKEA | 896 | O94964 | |
| RLKPEKAAEWEIHFA | 171 | P16471 | |
| DLKLFHIDKARDWTK | 71 | Q9Y6L7 | |
| VKTWTRHVDIFEKDF | 741 | Q9GZR1 | |
| LGEDWERTEVLHKKF | 186 | P02549 | |
| EEDRSAWKHAGALKK | 1581 | Q6ZT12 | |
| HWLEEAEKFAKTVVD | 446 | Q86TV6 | |
| EESSKRAELEKWHLE | 456 | Q9UH65 | |
| IDEDGKSHWVFESRK | 96 | Q9NYZ1 | |
| KSHWVFESRKESSQE | 101 | Q9NYZ1 | |
| IADHADIEWKFARTK | 631 | Q9UL62 | |
| EDGKSHWIFEARKVS | 96 | A6NH52 | |
| KHGSIEADFRAWKTK | 221 | Q9NV66 | |
| HIFFDAAKNLVWKER | 1886 | Q9BXT5 | |
| CLEKVDAFEERHKSW | 216 | P51580 | |
| QHDKARAVWLTAFEK | 1651 | O60293 | |
| TTAVAEAWARLDHKF | 381 | Q9BQE3 | |
| DEDTRHLSRKFKDWA | 396 | Q9HBA0 | |
| DSIFKWFSDLTKHKR | 416 | O14628 | |
| LIADHADIEWKFART | 626 | Q9UBN4 | |
| KKFEEHAVEALWKAV | 71 | P49815 | |
| EKETWKVSNKFHLEA | 676 | Q9NUA8 | |
| EVLSKKGHSFEVDVW | 221 | P53350 | |
| FTDDLHKLVDDWTKE | 1646 | Q9BYP7 | |
| DHLWNELEKFRKSEE | 2846 | Q14789 | |
| HKLKVRAESFDTWAN | 761 | P41229 | |
| KAEAHFERSWVLAVD | 231 | Q6P5S2 | |
| RLYTEAWDKDKTTVH | 2721 | P20929 |